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Humans evolved from primate ancestors who relied heavily on their vision for 
survival. To survive, they learned from visual information and then decided on the 
most appropriate behaviour for that situation. Visual information has been so essential 
to human survival that the optic nerve, which connects the eye to the brain, has 
evolved to become one of the densest nerves in the human body, containing  millions of 
axons1-5. These bundles of axons connect to the basal aspect of the brain and from 
there, other neurons take over the task. These nerve bodies subsequently connect with 
the terminus of visual pathway, the visual cortex, which is located at the back of the 
brain. 
! Despite the crucial importance of these visual pathways, many aspects of their 
functioning are only now being  elucidated. In particular, their relationship with 
ophthalmic pathology remains  poorly understood. This introductory chapter 
describes the knowledge a priori to the experimental studies which are described in 
Chapter 2, 3, 4, and 5. 
1.1. Aim and outline of this thesis
This thesis describes a number of magnetic resonance imaging  studies of the human 
visual pathway in participants with two prevalent causes of visual field defect due to 
ophthalmic pathology: macular degeneration and glaucoma. The main research 
question was whether these ocular pathologies, with their associated visual field 










The first chapter addresses the basic anatomy and physiology of the eye and brain, 
vision and the relevant pathologies. The methodological approaches used in the 
studies are described in the chapters to follow. The next four chapters describe the 
experimental studies that were performed to answer the main question. Chapter 2 
describes the first investigation on the density of the primary visual cortex grey matter 
in subjects with glaucoma and subjects with age-related macular degeneration. As the 
first follow-up study, further morphometric exploration of the visual pathway in the 
two major types of macular degeneration, the age-related and the juvenile type, is 
described in Chapter 3. For purposes of comparison, similar morphometric 
explorations in primary open-angle glaucoma are reported in the Chapter 4. In 
Chapter 5, the integrity of the visual pathway in glaucoma is further assessed by 
means of an imaging  technique specifically geared towards imaging nerve fibres. 
Finally, Chapter 6 contains a general discussion of the work presented in this thesis. 
1.2. Anatomy of the visual pathway
The term visual pathway refers to the structures connecting  the eye to the visual 
brain. These include the neuro-sensory retina of the eye,  the optic nerve, chiasm and 
tract, the lateral geniculate bodies, and the visual cortex.
1.2.1. The eye
The human eye is an intricate combination of an efficient optical system and an 
intricate bio-electrical signal processing system. The function of the optics is to 
transmit and refract the light entering  the eye so as to fit the structural 
arrangement of the retina, which senses the light entering the eye and processes 
the light into electrical signals. 
! Starting  from the foremost part of the eye, the optical system consists of 
the cornea, aqueous humour, lens and vitreous body. All  of those components, 
except for the lens, are relatively fixed in terms of their refractive power. The 
lens, which is suspended on a set of ciliary muscles, can change its refractive 
power by altering its convexity. Ideally, the optical system continuously focuses 
the light onto the central part if the retina to form a sharp image there. Less 
focused rays fall onto the peripheral retina. All of these rays of light are 
processed by the retina.
! The processing stream of the retina starts from signal transduction, in 
this case the transformation of light photons into electrical currents.  The 
photoreceptors occupying the outer segment do this task. These electrical 
signals are carried from cell to cell by means of interneuronal synapses. The 
next neuron to receive these signals is the bipolar cell,  which then transmits 
them to the retinal ganglion cell (RGC). The axons of the RGCs form the 
retinal nerve fibre layer (RNFL) and subsequently converge at the optic nerve 
head to form a bundle, which is popularly known as the optic nerve.* 
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*  This, however, is a misnomer. The fact that the optic nerve is consisted of the axons from  third order 
neurons makes it a tract rather than a nerve5. The proper optic nerve  should then be the axons of the 
bipolar cells. Nonetheless, for the sake of simplicity, we will just call the  bundle  of axons exiting the eyeball 
as the optic nerve, as popularly known.
1.2.2. Optic nerve, chiasm, and tract
The optic nerve is a collection of axons originating from the layer of RGCs. 
The bundle coming from one eye diverges halfway; some of the axons cross the 
midline to reach the contralateral side of the brain,  while the others stay on the 
ipsilateral side. This midline half-crossing  or hemi-decussation occurs in the 
chiasm. In this way, the chiasm contains both non-crossing and crossing fibres. 
The fibres coming from temporal side of the retina follow its course 
ipsilaterally, whereas the fibres from nasal side cross the midline. 
! After crossing and forming  the chiasm, the crossing fibres from the left 
eye and the non-crossing  ones from the right eye form a bundle called the right 
optic tract. A similar rule applies to the left optic tract. These tracts reach the 
basal aspect of the diencephalic part of the brain, where they form synapses 
with a group of neuronal cell bodies called the lateral geniculate bodies (LGB).
1.2.3. Lateral geniculate body and the geniculocalcarine 
radiation
Signals travelling  through the optic tract are relayed by synapses to the 
neurons of the LGB. In these structures, both the cell bodies and the axons 
projecting  out from them maintain their retinotopy, i.e. they maintain their 
relative spatial arrangement as it was in the retina. From these two nuclei, thin 
structures containing the axons that run on the lateral side of the lateral 
ventricles fan out to reach the calcarine fissures, hence the name 
geniculocalcarine radiation. The geniculocalcarine radiation is often called the 
optic radiation; these terms can be used interchangeably .
! The fibres carrying  the signals originating  from the central part of the 
retina terminate at the posterior end of the calcarine fissures, occupying  the 
poles of the occipital lobe. The fibres carrying the signals from the peripheral 
retina terminate more anteriorly in the fissures. The ends of fibres in the visual 
cortex are therefore retinotopically arranged.
1.3. Visual field
The anatomy of human eyes and their surrounding structures of orbit and eyelids 
normally determine the width of the visual field. From the fixation point, the visual 
field extents approximately 60° in the superior and nasal field, 75° in the inferior field, 
and slightly beyond 90° in the temporal field6.
1.3.1. Measurement of the visual field
The visual field is the field of vision when the eye fixates on a single point. The 
width and the sensitivity of the field is then measured while maintaining the 
fixation. Quantitative measurement of visual field is called perimetry. Perimetry 
is routinely done monocularly, where the fields of the right and left eyes are 
measured separately. 
! Two perimetry methods are commonly used in the clinic: kinetic and 
static perimetry. Kinetic perimetry is performed by moving a light stimulus 
over the visual field. Since the stimulus can be varied in size and intensity, 
using one stimulus at a time enables an investigator to map the boundaries of 
the visual field sensitivity. It is commonly done using Goldmann perimeter. 










from the fixation point. Static perimetry is performed by presenting  light 
stimuli at several fixed locations over the visual field, one at a time, while 
varying the intensity. This method usually allows measurement of the central 
30° of visual field. Automated static perimetry, conducted with instruments 
such as the Humphrey Visual Field Analyzer, is currently one of the 
commonest procedures in eye clinics. Such instruments can detect any defect 
up to 30° from central vision, and they automatically generate a sensitivity 
deviation map of the visual field, thus reducing the potential subjective bias in 
the measurement.
1.3.2. Visual field defect
With some types of  ophthalmic pathology,  the visual field can be impaired 
locally or globally. The impairment can be either temporary or permanent, and 
can be stable or progressive. Various ocular and cerebral conditions may impair 
the field. Two of the commonest causes of ocular field defect are glaucoma and 
macular degeneration. These two conditions are distinguished by the typical 
location of the defect. Glaucoma typically causes a peripheral visual field 
defect, which progresses centripetally and ultimately leaves the most central 
portion of the field intact.  As the name implies, macular degeneration disrupts 
the central visual field, leaving the peripheral visual field intact.
1.3.2.1. Visual field defect in glaucoma
Glaucomatous visual field defects may take any of five typical forms: 
nasal step, wedge, arcuate, constriction and/or depression7. These forms 
depend on the stage of the disease The defect typically starts from the 
nasal field (nasal step), sometimes connects to the (enlarged) blind spot 
on the temporal field, together forming  a bow-shaped defect called the 
arcuate defect. In the end stage, some patients have only residual 
sensitivity on the temporal field (temporal island) and some other 
patients have small residual central visual field (tunnel vision). 
Ultimately glaucoma leads to total blindness.
1.3.2.2. Visual field defects in macular degeneration
The structural degeneration in this pathology takes place in the central 
part of the retina, the macula. Because the macula with its fovea 
provides central vision,  this condition results in a central visual field 
defect. This can be a relative or an absolute depression in the central 10° 
of the field of vision. And as the name implies,  the peripheral visual field 
is spared.
1.4. Glaucoma 
Glaucoma is an umbrella term for a collection of diseases primarily characterised by 
progressive visual field defect8. In primary open-angle glaucoma (POAG),  intraocular 
pressure is one of many risk factors and is often increased8-11. Other risk factors 
include the presence of family history of glaucoma and myopia8, 12, 13.  RGC death is a 




The chromosomal loci associated with POAG are numerous, and have been 
detected on chromosomes 1, 2,  3,  4, 5, 7, 8, 9, 10, 15, 19, and 2014. Distortion of 
lamina cribrosa, extracellular matrix changes in the optic nerve, disruption of 
the microcirculation at the optic nerve head and increasing intraocular pressure 
may all be involved in the development of glaucoma15.  Numerous genetic 
dispositions and other mechanisms of RGC loss with POAG16-21  confirm the 
multifactorial nature of glaucoma aetiology. 
1.4.2. Symptoms and signs
In an early stage of glaucoma, the peripheral visual field may be loss.  For 
example, an individual may go to an ophthalmologist because he or she have 
difficulty climbing  or descending stairs due to the loss of inferior visual field. 
However, another individual with POAG might seek medical help only when 
the disease is already beyond the early stage. This could be due to the nature of 
the progressive visual field loss, which starts from the periphery and progresses 
centripetally. Because most activities rely on central vision, any defect or 
deterioration of the peripheral field might go unnoticed until it creeps into the 
central vision. During the late stage of this condition, peripheral vision may 
become very limited, while central vision remains relatively unaffected. In the 
worst case, vision is lost entirely. Ophthalmologic examination typically reveals 
quantifiable and relatively consistent, yet progressively worsening visual field 
sensitivity.
1.4.3. Brain studies pertaining to POAG
The brain has not usually been implicated in glaucoma. However, several 
recent studies have indicated an association between glaucoma and 
morphometric changes in the brain.  A postmortem study indicated that  the 
size of the optic nerve, the LGB, and the thickness of the visual cortex, is 
reduced in glaucoma22.  Involvement of the LGB22-24,  the visual cortex22, 24,  25, 
and the interconnecting white matter (tracts)26, 27 has been reported. 
1.5. Macular degeneration 
In contrast to glaucoma, individuals with macular degeneration commonly seek 
medical help at an early stage. This is due to the nature of central vision involvement 
in macular degeneration28-30. Central vision is used in virtually every activity of daily 
living. Blurred or distorted central vision is definitely troublesome, so help is sought 
immediately.
1.5.1. Aetiology
No conclusive research has yet been published on the exact cause of macular 
degeneration. However, the pathology is known to begin with basal or 
choroidal capillary leakage31, which is due to a dysfunctional blood retinal 
barrier32. This process may or may not advance to continuous leakage and 
neovascularization31,  which leads to macular oedema. The involvement of 
nutrient deficiencies in the aetiology of macular degeneration (concerning 
nutrients such as lipofuscin, lutein or zeaxanthine compounds, vitamin A or 










1.5.2. Symptoms and signs
The disruption of macular anatomy, especially involving  the fovea, causes the 
image that falls onto the area to lack sharpness or even become distorted30, 37. 
Moreover,  deposited materials and fluid accumulation in the foveal area may 
hinder incoming light, thus generating a positive scotoma: an appearance of 
something dark that ‘floats’ and blocks the central vision. 
! Based on the onset of the disease, macular degeneration can be classified 
into the senile type (age-related macular degeneration or AMD) and the 
juvenile type (juvenile-type macular degeneration or JMD). AMD can be 
further classified into dry/non-exudative and wet/exudative/neovascular AMD. 
In wet AMD, the decrease in visual acuity is caused by intraretinal and/or 
subretinal fluid  and haemorrhage, which may block the incoming light. 
Meanwhile in dry AMD, vision loss may be due to geographic atrophy38, 39, 
presumably caused by photoreceptors layer disruption due to retinal pigment 
epithelial (RPE) degeneration. 
! The impairment of the central vision occurs early in life in juvenile-type 
macular degeneration (JMD). JMD includes Stargardt’s disease (the most 
common form39), Best’s disease, juvenile retinoschisis40  and other diseases, and 
the retinal pathology varies accordingly41, 42, such as foveal atrophy with 
surrounding yellowish flecks in Stargardt’s disease and yolk-like macular lesion 
in Best’s disease39.  The resulting  RPE degeneration in the macula may be 
related to the visual acuity loss.  
1.5.3. Brain studies pertaining to macular degeneration
A number of reports have been published on visual cortex function in various 
types of macular degeneration: age-related and various kinds of juvenile-type 
macular degenerations.  In many of these reports,  the primary visual cortex that 
primarily represents the macular area remains silent during  macular visual 
stimulation43-46,  while the activities in the more peripheral projection zone in 
the primary visual cortex are preserved.  However,  the presence of functional 
reorganisation of the primary visual cortex in macular degeneration is still 
controversial28,  43-45, 47-50.  The relationship between the presence of macular 
degeneration and any structural deviation in the primary visual cortex is also a 
matter of some controversy, with some investigators suggesting  an absence of 
structural changes in macular degeneration51, while others suggest the 
existence of such changes 52. 
1.6. Structural brain imaging and the analyses
The advent of neuro-imaging  techniques has greatly advanced our understanding  of 
many neurological processes and of the pathologies of many kinds of diseases, 
including  those affecting  vision. For many modalities of neuro-imaging, magnetic 
resonance imaging (MRI) has been used extensively and intensively in both routine 
clinical and experimental practice. This is due to its relative safety and the high quality 
of the images that MRI can generate. High resolution brain tissue images can be used 
to identify and assess brain structures. 
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Structural MRI may require several types of acquisition, for example T1- and T2-
weighted acquisition. Although T1-weighted imaging  can produce high resolution 
anatomical images, this acquisition does not allow us to optimally differentiate 
projections or fibres connecting different brain areas. For this purpose, diffusion 
tensor imaging (DTI) was developed. 
1.6.1. Underlying concepts of MRI
The human body consists of 70% water by volume. A water molecule, H2O, 
contains two protons (hydrogen atoms).  The spin of these protons defines the 
magnetic field of the molecule. By applying  a strong  magnetic field to part of 
the body, the brain for example, the protons in water molecules will be aligned 
almost uniformly.  A certain amount of energy (a pulse) can be delivered to 
change the alignment of a group of protons in the brain. When the pulse is 
stopped, the protons begin to return to their normal alignment. While returning 
to normal alignment,  they release the energy received from the pulse. This 
energy is received by the MRI machine, where it is transformed into an image.
1.6.2. Voxel-based morphometry
Anatomical MRI allows us to inspect the human brain in vivo with resolution 
to the millimetre scale.  This allows an observer to perform manual quantitative 
measurements of many brain structures with a digital calliper. However,  this 
manual measurement raises the issue of inter-observer variation in the result, 
even when the measurements are taken by competent neuro-radiologists or 
neuro-anatomists. As with many other assessments, individual or subjective 
bias of measurement has been a potential problem, especially if such 
assessments must be very precise. This issue triggered the development of 
automated measurement technique, sometimes called automated morphometry, 
which minimises the involvement of human judgement in measuring brain 
structures in terms of their volume or density. 
! Thus far, automated morphometry has been used more often in research 
than in clinical settings.  This is because automated morphometry uses many 
different approaches developed by different groups of researchers. Due to the 
absence of a standard approach, the clinical use of this technique is still limited. 
However, the development of automated morphometry is ongoing and we can 
expect further advances in the future.
! One of the approaches for performing such morphometric analyses 
involves statistical analyses, such as voxel-wise comparison53-59. This approach 
relies quite heavily on the processes of image registration and segmentation. 
The registration process allows many different brain images to be compared on 
a voxel-by-voxel basis. Meanwhile, to increase the sensitivity of the statistical 
tests,  the grey and white matter and the cerebrospinal fluid are separated from 
each other using  automated segmentation procedures. This step allows the 
comparison of one type of brain tissue (e.g. grey matter) between individual 










For the present study I used VBM, which is included in the SPM8 software 
package (Wellcome Department of Imaging  Neuroscience, London, UK; http://
www.fil.ion.ucl.ac.uk/spm), to compare the volume of subcortical structures 
between the glaucoma group and control group60.  VBM statistically assesses 
local changes in grey and/or white matter volume between groups of 
anatomical scans.
1.6.3. Diffusion-weighted image-based analysis
Water molecules tend to diffuse with equal probability in all  directions. Given a 
certain amount of time, the diffusion will therefore be spherical.  This is called 
isotropic diffusion. However, in tubular structures, such as vessels in the brain, 
diffusion is more likely to occur along  the longer axis. The overall probability 
of diffusion will therefore be ellipsoidal, This is called anisotropic diffusion. 
The anisotropy becomes higher as the diameter becomes narrower and the 
longer axis is stretched out, as with axons.
1.6.3.1. Image acquisition and pre-processing 
DW images are prone to water-fat shift artefacts. This is readily visible 
in the frontal lobe. To correct for these artefacts, two acquisitions with 
opposing  directions were performed: (1) anterior-posterior (AP); and 
(2) posterior-anterior (PA). The two resulting  images were then 
independently eddy-corrected to correct for movement artefact due to 
the eddy current inside the scanner. 
! The next step was the susceptibility correction,  which takes 
advantage of the two images acquired with opposing  direction as 
explained earlier. This was done using a script provided by Farrell61. 
The susceptibility-corrected image was further processed for tensor 
estimation or fibre tracking (tractography). 
1.6.3.2. Tensor estimation 
The tensor estimation step, as implemented in DTIFIT (a tool available 
within FMRIB  Software Library or FSL),  yielded three eigenvectors 
(V1, V2, and V3), and three eigenvalues (!1,  !2, and !3) which are scalar. 
From the three eigenvalues, various invariants can be calculated, 
including  the fractional anisotropy (FA).  The FA was computed using 
the following formula:
A completely spherical diffusion (isotropic) has an FA value of 1,  while 
a completely anisotropic diffusion will be 0. 
1.6.3.3. Tract-based spatial statistics 
Tract-based spatial statistics (TBSS) was developed by Smith et al.62. 
This method tackled the problem of how to register FA images from 
multiple subjects and circumvented the problem of choosing  the 
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appropriate amount of smoothing needed prior to voxel-wise statistics. 
This was done by (1) non-linearly aligning multiple subject FA images 
to achieve reasonable alignment; (2) creating a mean FA image; (3) 
skeletonising  the mean FA image by suppressing low FA voxels; (4) 
projecting  the aligned individual FA images onto the skeletonised mean 
and filling the skeleton with the maximum FA value from relevant 
voxels in the search area; (5) performing voxel-wise statistics on the 
skeleton space across subjects without any need of smoothing.
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Retinal lesions caused by eye diseases such as glaucoma and age-related macular 
degeneration can, over time, eliminate stimulation of parts of visual cortex. This 
could lead to degeneration of inactive cortical neuronal tissue, but this has not 
been established in humans. Here, we used magnetic resonance imaging to assess 
the effects of prolonged sensory deprivation in human visual cortex. High-
resolution anatomical magnetic resonance images were obtained in subjects with 
foveal (age-related macular degeneration) and peripheral (glaucoma) retinal lesions 
as well as age-matched controls. Comparison of grey matter between patient and 
control groups revealed density reductions in the approximate retinal lesion 
projection zones in visual cortex. This indicates that long-term cortical deprivation 
due to retinal lesions acquired later in life is associated with retinotopic specific 
neuronal degeneration of visual cortex. Such degeneration could interfere with 
therapeutic strategies such as the future application of artificial retinal implants to 
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Age-related macular degeneration (AMD) and glaucoma, eye diseases associated with 
the occurrence of visual field defects, are the two leading  causes of visual impairment 
in the developed world1. AMD is caused by accumulated waste products in the tissues 
underneath the macula that interfere with retinal metabolism and lead to retinal 
atrophy2, 3.  The disease causes field defects that are located in or near the central 
visual field. In glaucoma, progressive retinal ganglion cell loss and optic nerve damage 
occurs, in most cases induced by an elevated intra-ocular pressure4, 5. Visual field 
deterioration typically starts peripherally and progresses towards the fovea. Due to 
the retinotopic organisation of the visual cortex6, 7, when field defects occur in both 
eyes and overlap, the corresponding part of visual cortex is no longer stimulated. An 
absence of stimulation may result in changes in the cortical structure8, 9. This makes it 
relevant to ask whether field defects that have their origin at the level of the retina can 
lead to deterioration in the structure of the occipital cortex. 
! Indeed, there is evidence that developmental visual disorders such as 
amblyopia10 and albinism11  affect the structure of human occipital cortex. However, 
surprisingly little is known about the consequence of visual deprivation later in life. A 
recent case study showed degenerative changes in the visual cortex of a glaucoma 
patient based on post-mortem examination12. Previously, using  magnetic resonance 
imaging, Kitajima and colleagues had reported wider calcarine sulci in a small group 
of patients with a variety of retinal pathology indicating a possible link between visual 
field defects and cortical degeneration13.  In another study, compared to healthy 
participants, subjects with normal-tension glaucoma, but not those with glaucoma, 
showed more pathological findings (ischemia) in sulci, fissures, subarachnoid spaces, 
and ventricles14. However, the status of the grey matter was not examined. Finally, in 
glaucoma patients, a reduced size of the lateral geniculate nuclei was reported15. 
! In the present paper, we determined whether structural changes in human 
visual cortex occur once disease of the eye has resulted in an established homonymous 
visual field defect. This question is also relevant given conflicting  reports on the 
presence of functional occipital reorganisation following retinal lesions16-19. In the 
present study, visual field measurements were used to chart changes in visual 
sensitivity associated with the retinal visual field defects from AMD and glaucoma. 
Magnetic resonance imaging and subsequent voxel-based morphometric analysis 
methods were used to selectively assess the presence of any associated changes in grey 
matter density in the two groups. 









2.2. Materials and methods
2.2.1. Subjects
Subjects with visual field defects were recruited amongst the patient population 
of the Department of Ophthalmology of the University Medical Center 
Groningen (Groningen, The Netherlands) and through advertisements in 
magazines of patient associations. The group consisted of nine patients 
suffering  from AMD (two females and seven males; mean age 73 years-old, 
range 51 – 82 years-old),  and eight patients with primary open-angle glaucoma 
(one female and seven males; mean age 72-years-old, range 61 – 85 years old). 
! Age-related macular degeneration was defined as the presence of a 
decreased visual acuity in a patient with abnormalities in the macular area 
without any other explanation. Abnormalities might be either drusen, hyper-/
depigmentation, geographic atrophy or signs of previous exudative changes. A 
glaucoma patient was defined as a patient with a reproducible visual field 
defect on conventional perimetry. The defects had to be compatible with 
glaucoma and without other explanation. Optic disc excavation had to be in 
line with glaucoma as well. In addition,  in both AMD and glaucoma groups, 
patients had to have an homonymous scotoma of at least 10 degrees diameter in 
at least one quadrant, for a minimum of 3 years.  Patients with any other 
(neuro-)ophthalmic disease that might affect the visual field were excluded. 
! Homonymous visual fields defects in both groups were located centrally 
or paracentrally.  In glaucoma,  the visual field defect generally starts 
paracentrally, progresses peripherally and finally expands towards central parts 
in the last stage of the disease.  This difference in location and severity of visual 
field losses is reflected in the visual acuity (logMAR; logarithmic minimum 
angle of resolution) and in the mean deviation (MD) scores of both groups. 
LogMAR is a logarithmic transformation of the more common clinically used 
decimal notation. A logMAR value of 0 corresponds to a visual acuity of 1.0 in 
decimal notation. More positive numbers indicate that the minimum angle of 
resolution is larger, and thus correspond to a lower visual acuity. The mean 
deviation is the weighted average decrease in visual field sensitivity relative to 
the norm for a particular age group.  Negative values indicate a reduced 
sensitivity. Table 1 lists these characteristics. 
! For the control group, 12 healthy age-matched subjects (three females 
and nine males; mean age 66 years,  range 60-82) were recruited. They were 
recruited from amongst the partners of the visual field impaired participants or 
via advertisement in a local newspaper. Control subjects were required to have 
good  (or corrected to good) visual acuity (logMAR!0), not to have any visual 
field defect and to be free of any ophthalmic, neurologic, or general health 
problem. 
! This study conformed to the tenets of the Declaration of Helsinki and 
was approved by the medical review board of the University Medical Center 
Groningen (Groningen, The Netherlands).  All participants gave their informed 
written consent prior to participation. 
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Subject Group Age
Visual acuity (logMAR) Visual field mean deviation (dB)
OD OS OD OS
1 AMD 74 1.8 1.3 n/a -7.57
2 AMD 67 0.5 0.1 -5.5 -4.50
3 AMD 62 1.3 0.7 -11.48 -2.69
4 AMD 82 1.1 1.0 -6.28 -4.96
5 AMD 78 1.0 1.8 -3.51 -7.04
6 AMD 81 1.1 0.7 -6.06 -3.64
7 AMD 76 0.5 0.8 -5.79 -2.64
8 AMD 51 1.0 1.0 -12.01 -14.08
9 AMD 82 0.5 0.4 -3.43 -2.20
Mean 72.6
10 POAG 66 0.1 0.1 -25.08 -22.96
11 POAG 69 0.1 0.1 -27.20 -13.82
12 POAG 85 0.0 1.0 -8.80 -24.59
13 POAG 80 0.2 0.1 -5.23 -16.15
14 POAG 64 l.p. 0.7 l.p. -14.45
15 POAG 61 0.05 0.05 -11.62 -3.67
16 POAG 74 0.0 0.1 -23.28 -18.27
17 POAG 79 0.1 0.15 -6.36 -13.41
Mean 72.3
Table 1. Subject characteristics. Characteristics of the two patient groups (AMD and glaucoma) were visual 
acuity for one or both eyes (expressed in logMAR), visual sensitivity (expressed as MD in dB), and age. 
logMAR – logarithm of minimum angle of resolution; MD – mean deviation; dB – decibel; AMD – age-related 
macular degeneration; POAG – primary open-angle glaucoma; l.p. - light perception; n/a – not available.
2.2.2. Visual field measurements
Visual fields were recorded using the Humphrey Field Analyzer (Carl Zeiss 
Meditec, Dublin,  California, USA) running  the 30-2 program SITA (Swedish 
Interactive Threshold Algorithm)-Fast, a standard method for the examination 
of the 30 degree central visual field.  In this type of measurement, the subject is 
facing a white illuminated sphere, on which points of light with varying 
intensities are briefly flashed. The subject has to fixate a set of centrally 
positioned fixation points during the measurement. Stimuli are presented one 
by one on a grid in the central 30 degrees of the visual field. Subjects respond 
when they perceive the flash.  The sensitivity at each location in the visual field 
is determined by changing the intensity of the flash on subsequent 
presentations. Each eye is measured independently, one eye is covered while 
the other is tested. 
! To assess the relationship between the reduction in visual field 
sensitivity and changes in cortical grey matter density, for each group, mean 
sensitivity deviation maps were calculated. This was done in two steps. First, 
for each subject, a combined visual field map was created by taking at each 









position the smallest sensitivity deviation from the left and right eye’s 
monocular measurements.  Second, the combined maps from all subjects in a 
group were averaged to yield an average binocular sensitivity deviation map for 
each group. 
2.2.3. Magnetic resonance imaging
High-resolution magnetic resonance imaging was performed on a 3.0 Tesla 
Philips Intera (Eindhoven, The Netherlands). A three-dimensional structural 
image was acquired on each subject using a T1-weighted magnetisation 
sequence T1W/3D/TFE-2, 8 degrees flip angle, repetition time 8.70 ms, matrix 
size 256 x 256, field of view 230 x 160 x 180, yielding 160 slices, voxel size 
1x1x1 mm.
2.2.4. Voxel-based morphometric analysis
We performed voxel-based morphometry analysis20, which is part of the SPM5 
(Statistical Parametric Mapping) software (Wellcome Department Imaging 
Neuroscience, London, UK; http://www.fil.ion.ucl.ac.uk/spm). Voxel-based 
morphometry statistically assesses local changes in grey matter density between 
groups of anatomical scans. The brain images were registered to the 
International Consortium for Brain Mapping space template. Using the 
standard segmentation protocol in SPM5, each voxel was classified into one of 
the 3 different tissues: grey matter, white matter and cerebrospinal fluid. Non-
brain voxels were excluded from the statistical analysis by applying a brain 
mask. Finally, the images resulting  from the segmentation were smoothed with 
a gaussian kernel of 10-mm full-width at half-maximum. 
! For the statistical analysis, two contrasts were defined, the first 
comparing grey matter density in the AMD group and the control group, the 
second comparing grey matter density in the glaucoma group and the control 
group. Even though the participant groups were age-matched, there were some 
slight differences in the age distribution. The subjects’  age was therefore added 
as a covariate to the analysis as an additional measure to control for any 
potential remaining effect of age.
2.2.5. Volume of interest based analysis
In addition to the voxel-based morphometric analysis, an anatomical volume-
of-interest (VOI) analysis was performed. For this analysis,  in each individual 
participant, 21 mm diameter sphere VOIs were defined at the location that 
corresponded to the approximate expected anatomical position of the foveal 
and peripheral visual field representations. In each hemisphere,  posterior (at 
the occipital pole; foveal projection zone) and anterior (approximately 10 mm 
posterior to the junction of parieto-occipital and calcarine sulci) VOIs were 
defined in both the superior and inferior banks of the calcarine sulcus. Mean 
grey matter density values were extracted from each subject’s grey matter for 
each VOI and averaged over groups.  For each VOI, relative grey matter 
densities were calculated for the AMD and glaucoma group by dividing mean 
grey matter values by those of the control group. Analysis of variance was used 
to examine the interaction between the factors group (AMD and glaucoma) 
and cortical location (posterior and anterior). 
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2.3. Results
2.3.1. Binocular visual fields
Figure 1 shows the binocular sensitivity deviation maps for six representative 
subjects, three from each group. Based on the individual maps, for each group 
a mean binocular sensitivity deviation map was calculated. These mean maps 
are shown in Figure 2D and 3D. 
Figure 1. Individual binocular  sensitivity deviation maps. Upper row shows maps for three representative 
subjects from the age-related macular degeneration (AMD) group, the lower row  shows maps for three 
subjects with glaucoma. Subject numbers correspond to those in Table 1. 
2.3.2. Visual cortex grey matter density
Figure 2D shows the mean visual field sensitivity deviation map for the AMD 
group. A reduction in sensitivity is evident centrally on and near the location of 
the fovea (< -6 dB). Figure 2A-C show the comparison of grey matter density 
in the AMD group compared to controls superimposed on the mean anatomical 
image of all subjects. In subjects with AMD, grey matter density is reduced 
compared to the control group. This main reduction in density is located near 
the occipital pole (primarily in the left hemisphere), particularly around the 
posterior part of the calcarine fissure (p<0.001). Figure 3D indicates that in the 
glaucoma group, mean visual field sensitivity is markedly reduced in the 
periphery of the visual field,  in both the upper and lower hemifields (< -8 dB). 
Importantly, in contrast to the AMD group, the sensitivity is relatively spared 
in the macular region. Figure 3A-C show the comparison of grey matter 
density between the glaucoma and control groups. The results indicate the 
presence of a bilateral reduction of grey matter density on the medial aspect of 
the occipital lobe, at the anterior half of the calcarine fissures (p<0.001). 









Figure 2. Analysis of subjects with age-related macular  degeneration. A-C: sections of the brain showing 
regions of grey matter density reduction. Colours indicate statistical significance (t-values), with red indicating 
more significant changes, and yellow/green indicating less significant changes (all changes are at least 
p<0.001, uncorrected). D: mean visual  field sensitivity deviation (in dB). The largest change in sensitivity is 
located centrally in the visual field. dB – decibel. 
Figure 3. Analysis of subjects with glaucoma. A-C: sections of the brain showing the regions of grey 
matter density reduction. Colours indicate statistical significance (t-values), with red indicating more 
significant changes, and yellow/green indicating less significant changes (all changes are at least p<0.001, 
uncorrected). D: mean visual field sensitivity  deviation (in dB). The largest changes in sensitivity are located 
peripherally in the visual field, leaving the macular region relatively unaffected. dB – decibel.
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Figure 4 shows the results of an additional volume-of-interest based analysis. 
For this analysis, on each participant’s brain, small sphere VOIs were defined 
that correspond to the approximate anatomical projection zones of the fovea 
and peripheral visual field. For each participant group, average relative grey 
matter density in the anterior and posterior VOIs is plotted. This analysis 
confirms the results of the voxel-based morphometric analysis. In the AMD 
group, the relative grey matter density is more reduced in the posterior than in 
the anterior region. The glaucoma group shows exactly the opposite result. 
Relative grey matter density is more reduced in the anterior than in the 
posterior region. This interaction was statistically significant (p<0.01). 
Figure 4. Results from a volume-of-interest based  analysis. Relative change in grey matter density for 
the age-related macular degeneration and glaucoma groups compared to the control  group in anatomically 
defined volumes of interest in posterior (approximate foveal projection zone) and anterior (approximate 
peripheral visual field projection zone) visual cortex. Relative changes were calculated by dividing for each 
participant group the averaged grey matter density in each volume-of-interest by that of the control group.
Figure 5 summarises the main results of this study, and shows the pattern of 
decrements in grey matter density in the glaucoma and AMD groups, as well as 
their respective (thresholded) sensitivity deviation maps. Retinotopically, the 
pattern of grey matter reduction that we find in our study correlates well with 
the pattern of changes in visual field sensitivity in both types of pathology. In 
AMD, the reduction in visual field sensitivity is most pronounced in the foveal 
region (Figure 5A). Corresponding with this, the focus of grey matter 
reduction in this group is located near the posterior pole of the occipital cortex 
(Figure 5A). 









Figure 5. Summary of visual field sensitivity and grey matter  reduction  in age-related macular 
degeneration (AMD) and glaucoma. A: cortical  grey matter density reduction in glaucoma is found in the 
anterior half of the medial occipital cortex  (cyan). Cortical grey matter density reduction in AMD (magenta) is 
found in the posterior part of the occipital cortex.  B: thresholded mean visual field sensitivity deviation maps 
indicating central defects in AMD (magenta) and more peripheral defects in glaucoma (cyan). For this 
thresholded map, for the glaucoma group, sensitivity deviations below –12 dB are shown in cyan. For the 
AMD group, sensitivity deviations below –8 dB are shown in magenta. 
In glaucoma, the main reductions in visual field sensitivity are located more 
peripherally (Figure 5B). Consistent with this,  the focus of the grey matter reduction 
in this group is located more anterior in occipital cortex (Figure 5A). 
2.4. Discussion
The main finding  of this study is that visual field defects caused by long-standing 
retinal pathology due to glaucoma and age-related macular degeneration (AMD) are 
associated with reductions in grey matter density in occipital cortex. Moreover, in 
both the AMD and glaucoma participant groups, the location of the grey matter 
density reduction corresponded with the approximate visual field defect projections in 
visual cortex. The more central scotoma of the AMD subjects correlated with a 
reduction located more posteriorly in occipital cortex, in correspondence with the 
location of the foveal representation in visual cortex. The difference was more 
pronounced in the left hemisphere. In agreement, the sensitivity deviation map shows 
a macular defect that was more pronounced in the right visual field. The more 
peripherally located scotoma in the glaucoma subjects correlated with a reduction of 
grey matter density located more anterior in occipital cortex. This is in 
correspondence with the location of the cortical representation of the peripheral visual 
field. Therefore, our results suggest that retinal visual field defects acquired later in 
life can lead to retinotopically specific grey matter density reduction in visual cortex. 
! An earlier report on this study21 reported no significant difference in grey 
matter density between the AMD and control groups. The analysis carried out in this 
preliminary report used SPM99 rather than SPM5 as in the present study. The 
difference in results can be attributed to improvements in the segmentation process 
where SPM5 reaches a more detailed segmentation than SPM99. The segmentation 
process in SPM5 takes advantage of a spatial normalisation that does not rely on the 
simple relationship between the intensities of two images. The segmentation is 
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achieved by warping  tissue probability maps in order to overlay them on to the image 
to segment. The obtained spatially normalised tissue class images of each subjects are 
averaged and used as prior probabilities for each voxel to belong to a particular tissue 
class22. Since this procedure is more refined and accurate, we report here the results 
obtained with SPM5. Nevertheless, we believe that discrepancies in results 
originating from differences in analyses should be considered serious issues and hence 
be reported. 
! Our present results indicate a good correspondence between the locations of 
the mean scotoma and the cortical regions showing  a reduction in grey matter density. 
When examining the results at a more detailed level, however, a number of factors 
may contribute to uncertainty (and thus deviations) in the correspondence. First, we 
rely on normalisation of the brains of the subjects. Normalisation, in particular in 
occipital cortex, is delicate due to anatomical variability. Second, there will be 
differences in how the functional visual field maps onto the anatomy. Third, we show 
the grey matter density reductions on the mean anatomical image of all participants. 
Each participant’s contribution to the average anatomy is equal. Yet,  the contribution 
to the group’s focus of the density reduction is not necessarily equal for each 
participant. Fourth, the extent of the cortical regions showing a reduction varies with 
the statistical threshold used. Finally, it is not a priori clear when (in terms of 
sensitivity deviation and diameter) a retinal scotoma will result in a reduction of grey 
matter density. We have here, for both the participant selection and analysis of the 
visual field, made the assumption that this is only in case of relatively large, 
homonymous scotoma. For this reason, we computed the binocular maps for 
individual participants using the minimum deviation in sensitivity and averaged these. 
Yet, grey matter density reduction may occur for monocular defects as well. A more 
extensive analysis including patients with different (also monocular) field defects 
would be required to indicate precisely how depth and extent of the retinal lesion is 
related to changes in grey matter density and functional anatomy of the visual cortex. 
! This study involved older participants, so the possibility that the reported 
changes are simply due to ageing  effects should be considered. Salat and colleagues 
showed that cortical thinning  due to ageing  may involve the primary visual cortex 
among  other cortical areas, although the correlation with age was only weak23. Raz 
and colleagues confirmed that regional volume change due to ageing in the visual 
cortex is very weak24. To control for possible ageing  effects, we made sure that the 
groups were on average age-matched. Our volume-of-interest based analysis indicates 
a slight overall reduction in grey matter density in both patient groups compared to 
the control group, in addition to the specific scotoma related reductions. In the voxel-
based comparisons of cortical grey matter density we included age as a covariate to 
remove any age-related residual influences. Hence, we are confident that the present 
results are not merely due to age. The generalised reduction in grey matter density 
observed in the VOI based analysis could be due to variability in the field defects. The 
defects in both patient groups, although primarily centrally located for AMD and 
more peripherally for glaucoma patients, do show some spreading between individual 
subjects (see Figure 1). Grey matter density reduction related to field defects that vary 
between the individual members of a patient group could show up as a generalised 
effect. Nevertheless,  for each patient group the location of the focus of the grey matter 
density reduction clearly corresponds to the expected lesion projection zone of mean 
visual field defect (Figure 2, 3 and 5). 









We believe this to be the first report that establishes a firm relationship between 
acquired retinal visual field loss and grey matter degeneration in human visual cortex. 
An earlier magnetic resonance imaging  study, had suggested calcarine atrophy to be 
related to retinal degeneration13.  However, the participants in this study had not only 
widely varying  retinal pathology, but also a relatively coarse measure of degeneration 
was used (width of the calcarine sulcus). Since no segmentation of grey and white 
matter was performed the findings need not be due to grey matter degeneration. A 
post-mortem study reported to have found a reduction of the cortical ribbon thickness 
in the visual cortex in glaucoma. However, this study reported on anatomical and 
histological examination of a single subject only12. 
! In glaucoma, cortical degeneration can be interpreted as a result of the loss of 
retinal ganglion cells. The atrophy from damaged parts of the retina likely propagates 
by means of transneuronal degeneration through the optic nerve towards the cortex 
thereby provoking  its subsequent degeneration. Experimentally, this sequence of 
events has been shown to occur in cats and monkeys where the retina was 
experimentally injured by an induced elevated intra-ocular pressure25. 
! In AMD, the relationship between retinal pathology and cortical  degeneration 
might be slightly more indirect, in that photoreceptor damage may first lead to retinal 
ganglion cell loss. It has been shown that the retinal ganglion cell count is significantly 
lower in wet AMD than in otherwise healthy eyes26. Eyes with geographic atrophy 
due to AMD also have lower count of retinal ganglion cells27. In agreement with the 
idea that cortical atrophy is linked to a reduction in retinal ganglion cell count and 
optic nerve damage, a voxel-based morphometry study reported abnormally reduced 
grey matter volume at the occipital poles of a group of human albinos11. There is no 
direct evidence demonstrating  that retinal ganglion cell loss occurred in our AMD 
group. However, a reduction in visual field sensitivity is linked to retinal ganglion cell 
loss and not to other components of the neuro-retina28, 29.  Moreover,  foveal sensitivity 
is greatly reduced in AMD. Together, this suggests the possibility that retinal ganglion 
cell loss does occur in AMD-associated visual field defects. This loss could be 
responsible for the cortical degeneration we have observed. 
! A number of studies have examined whether functional reorganisation 
accompanies retinal lesions. Thus far, reports have presented conflicting  results with 
some groups reporting  an absence of reorganisation18, 19 and others reporting  its 
presence16. This difference in findings has recently been attributed to differences in 
stimuli and tasks used in the various studies17. More cognitively engaging tasks 
appear to result in feedback signals from later visual areas that also drive neuronal 
activity in the lesion projection zones. Such feedback signals appear absent in visually 
healthy subjects. While one could argue that this indicates a form of functional 
reorganisation, it leaves open the question whether the lesion projection zone of 
primary visual cortex is still able to process retinal signals. This question is particular 
relevant given the rapid developments in retinal prostheses. Our study indicates a 
reduction in grey matter in the approximate lesion projection zones of primary visual 
cortex. Given that feedback signals still appear to be processed,  we speculate that the 
grey matter reduction reported on here could be selective to the input layers of 
primary visual cortex. 
! In summary, this study shows that long-standing visual field defects due to 
retinal pathology are associated with retinotopic specific grey matter reduction in 
early visual cortex. These findings contribute to the understanding of brain plasticity 
at later age. Besides,  from a clinical point of view, a better understanding  of the 
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relation between retinal visual field defects and structural changes in visual cortex 
may help understand disease symptoms as well as their progression. For instance, 
cortical degeneration may limit the efficacy of rehabilitation and training programs30, 
retinal prostheses31,  and may require new therapeutic strategies32, 33 to prevent 
blindness. Prevention of cortical degeneration associated with eye diseases may also 
need to become a new therapeutic goal. 
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Chapter 3
Morphometric analyses of the 
visual pathway in macular 
degeneration 
Based on: 
Hernowo AT, Prins D, Baseler HA, Plank T, Greenlee MW, Morland AB, Hooymans JMM, 










Macular degeneration causes central visual field loss and there have been reports 
on its effect on the functionality of the primary visual cortex. In this multicentre 
study, we used voxel-based morphometry on high resolution anatomical images to 
investigate the visual pathway structure of subjects with age-related and juvenile 
type macular degeneration (AMD and JMD, respectively). Compared to healthy 
controls, subjects with any type of macular degeneration showed lower volume of 
the visual pathway. However, the involvement of the pathway is more extensive in 
JMD group, starting from the pregeniculate structures up to the primary visual 
cortex. These findings showed that the presence macular degeneration is 
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World Health Organization indicated that in 2002 there were almost 37 millions 
(0.57%) blind people and another 124 millions (2%) had to live with low vision in the 
world, with age-related macular degeneration (AMD) and childhood blindness being 
the causes of the blindness in 8.7% and 3.9% of cases, respectively1.  In Europe,  retinal 
pathologies have been in the top five causes of visual loss in both childhood and 
adulthood2, and from those, AMD has again been the most common culprit in the 
adult population3.  
! Similar macular pathologies to AMD may start early in childhood or teenage, 
yet there is no singular disease entity. They are mostly inherited and since they start 
early in life, their period of illness are longer than of AMD. Commonly referred as 
juvenile-type macular degeneration (JMD), they include Stargardt’s disease, Best's 
vitelliform retinal dystrophy (Best’s disease), cone-rod dystrophy, central areolar 
choroidal dystrophy, and others. Visual field loss in both type of macular degeneration 
is primarily due to the loss of photoreceptors. While in JMD the pathology varies, the 
accumulation of sub-macular deposit called drusen in AMD compromise retinal 
metabolism  and leading to the degeneration of the macula with or without 
neovascularization4-7. 
! Structural brain changes due to non-use (no afferent or efferent) have also 
been reported in many conditions8, 9.  Macular degeneration produces central visual 
field defect (central scotoma),  which binocular overlaps lead to non-stimulation of the 
visual cortex10, 11, which may further changes the visual cortex structure12. Various 
retinal and optic nerve conditions are indeed found to be associated with cortical 
changes as thinning or grey matter loss12-14, and as well as with the more proximal 
visual pathway structures as volumetric reduction15.  These findings might indicate 
that the visual pathway structures are vulnerable to retinal and optic nerve 
pathologies, such as macular degeneration and glaucoma. This in turn raised a 
question whether macular degeneration might also affect the structural integrity of the 
the visual pathways. If it does affect the pathway, the clinical practice pattern in 
macular degeneration management might need to adapt itself in the best interest of the 
patients.  This question is also relevant given conflicting reports on the presence of 
functional occipital reorganisation following retinal lesions10, 16-21. Here, we reported 
our investigation on the visual pathway structure morphometry in macular 
degeneration patients and healthy control individuals.











Participants of this study were recruited from three university medical centres: 
York (United Kingdom),  Regensburg  (Germany), and Groningen (the 
Netherlands). This study conformed to the tenets of the Declaration of 
Helsinki and was approved by the respective medical review board of each 
centres in the study. The inclusion criteria required that subject must be free 
from neurological or psychiatric disorders, and having central visual field 
defect attributed to macular degeneration. All participants gave their written 
informed consent before participation. The participants with macular 
degeneration were classified into two groups: the ones with the juvenile type of 
macular degeneration (JMD) and the ones with the age-related type (AMD). 
In the beginning, there were 114 subjects participating  in this study:  25 with 
AMD, 34 with JMD, whereas the remaining  55 were the healthy controls. 
However, one subject with AMD decided to quit the study, leaving in total 113 
included in the analyses.
! The control subjects mean age was 49.6 years (range 13 to 83 years), 
and 46% of them were males. From those controls, 22 subjects were age-
matched (mean age 68, range 61-83 years) to AMD group. The other 33 
subjects (mean age 37.4, range 13 - 60 years) were age matched to the JMD. 




Number of subjects 24 34
Age, mean (range), years 75.2 (52 - 91) 40.2 (12 - 66)
Female, sex, % 42 38
Visual acuity in logMAR, mean (range)
OD 0.96 (1.60 - 0.50) 1.12 (3.00 - 0.30)
OS 0.88 (1.80 - 0.10) 1.16 (3.00 - 0.66)
Scotoma diameter, mean (range), degree 14 (4 - 25) 20 (3 - 65)
Table 1. Baseline patient characteristics. Characteristics of the two patient groups (AMD and JMD) were 
age, sex  proportion (in percentage), visual acuity for one or both eyes (expressed in logMAR), and scotoma 
diameter (expressed in degree). AMD – age-related macular degeneration; JMD – juvenile type macular 
degeneration; logMAR – logarithm of minimum angle of resolution; OD - right eye (oculus dexter); OS - left 
eye (oculus sinister).
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3.2.2. Magnetic resonance data analyses
Since the datasets were from three different study centres, the acquisition 
parameters were different. However, all of the acquisitions were of 1 mm ! 1 
mm !  1 mm resolution. Magnetic resonance (MR) imaging were done in three 
different scanners. Groningen datasets were acquired on a 3.0 Tesla Philips 
Intera (Eindhoven, The Netherlands), at the MRI Centrum, University 
Medical Center Groningen. A three-dimensional structural image was acquired 
on each subject using a sequence T1W/3D/TFE-2, 8º flip angle, repetition time 
8.70 ms, matrix size 256 !  256, field of view 230 !  160 !  180, yielding  160 
slices.  York dataset were acquired using 8-channel, phase- array head coils on 
either a Siemens Trio 3 Tesla at the Combined Universities Brain Imaging 
Center (Royal Holloway University of London), or on a GE 3-Tesla Signa HD 
Excite scanner at the York Neuroimaging Center (University of York). Multi-
average, whole-head T1-weighted anatomical volumes were acquired for each 
participant. Sequences used were 3D-MDEFT on the Siemens Trio or 3D-
FSPGR on the GE Signa. Regensburg dataset were acquired on a 3.0 Tesla 
Allegra Scanner (Siemens, Erlangen, Germany). One hundred and sixty slices 
covering  the whole brain, FOV=256!256 mm2 were obtained from each 
subject, using the ADNI sequence (TR = 2250 ms, TE = 2.6 ms,  flip angle 9°) 
taken at Laboratory for Neuro Imaging, UCLA, Los Angeles, US. 
" We defined six regions-of-interest (ROIs) along  the visual pathway: 
pregeniculate structures (pgcl), lateral geniculate bodies (lgb), 
geniculocalcarine radiation (gcr), occipital pole (ocp), the intracalcarine (icc) 
and supracalcarine regions (scc).  For the first three ROIs, the brain images 
were cropped so that the desired ROI is captured with minimum extra-ROIs 
structure.  For the second three ROIs, the occipital lobes of the brains were 
cropped and used. The image processing  involved the following  steps:  rigid-
body registration, segmentation,  registration,   and modulation of the segments. 
Image processing for the AMD group and its age-matched controls  were done 
separately from the JMD group and its age-matched controls. Finally 
volumetric comparison of different tissue segments between the patients and 
control groups within the visual pathway were performed. The process from 
the segmentation to the voxelwise statistical analyses is known as voxel-based 
morphometry or VBM, which is implemented in SPM8 software package 
(Wellcome Department of Imaging Neuroscience, London, UK; http://
www.fil.ion.ucl.ac.uk/spm)22. VBM statistically assesses local changes in grey 
and/or white matter volumes between groups of anatomical scans. The steps in 
the data analysis procedure are described in more detail below.
3.2.2.1. Bias correction and noise reduction
The images were converted from their raw formats into analysable 
(NIFTI) format. We performed bias correction (implemented in SPM8 
segmentation tool) and noise reduction using SUSAN (Smallest 
Univalue Segment Assimilating Nucleus)23 prior to the next steps. 
SUSAN is available for free as a part of FSL (FMRIB Software 
Library).









3.2.2.2. Rigid body registration
We performed rigid body registration on the brains to a common 
template using  SPM8’s tool for co-registration. In this step, the brains 
are reoriented into the common template space using six linear 
transformation parameters: 3 translations and 3 rotations. All 
transformations are performed within 3-dimensional coordinate,  with x, 
y, and z as its axes. This rendered the images to have uniform 
dimensions and to be in approximate orientation to each other. 
3.2.2.3. Segmentation, registration, and modulation
We used SPM8’s DARTEL (Diffeomorphic Anatomical Registration 
through Exponentiated Lie Algebra) suite of tools24, 25.  DARTEL tools 
enabled us to create modulated gray and white matter images that were 
registered to a common reference image specifically representing  our 
sample. The study-specific approach we used here enabled a more 
accurate inter-subject registration of brain images with improved 
localization and sensitivity of the VBM.
! The process began with SPM8‘s segmentation which segmented 
the co-registered T1-weighted images, except for lateral geniculate 
bodies extraction. For the latter structure, we used FAST (FMRIB’s 
Automated Segmentation Tool) and feed the output into the DARTEL 
pipeline. After all the brains were segmented, a reference –or template– 
image was generated. The first step in generating this reference image 
was averaging  the images of all  brains. Following  this, the individual 
brains were deformed and registered as closely as possible to this 
reference image. Next, using  the registered brain images,  a new average 
reference image was created to which the individual brain images were 
again registered. After 6 of these averaging and registration cycles,  the 
final reference image was generated. The final reference image was then 
used as the template to which the native segmentations of the individual 
brains in the study were registered and modulated.  
3.2.2.4. Statistical analyses
There were three groups in the model: controls, AMD, and JMD. 
Group comparisons were performed while taking  into account the age as 
covariates. We performed two type of analyses: (1) region-of-interest or 
ROI-based analysis; and (2) voxel-wise analyses. In ROI-based 
analysis,  we used masks to extract the ROI volumes and investigate the 
distribution of the extracted values prior to choosing the appropriate 
statistical analysis.   The  ROI volumes were extracted from modulated 
normalised brain segments. While in voxel-wise analyses, we compared 
the brains voxel by voxel along the visual pathway. 
34
As we had mentioned earlier, the six ROIs we compared are pgcl, lgb, gcr, 
ocp, icc, and scc.  The masks used to extract the volume of the 
pregeniculate structures and the lateral geniculate bodies were manually 
made by the investigator, for the boundaries of those structures are 
feasible to define visually. The mask for the geniculocalcarine radiation 
were derived from Jülich histological atlas26, 27, whereas the mask for 
the occipital pole,  intracalcarine and supracalcarine regions were 
derived from Harvard Center for Morphometric Analysis28-31. 
! The second type of analysis was voxel-wise in nature (VBM). 
The method made it possible for the investigators to spatially detect any 
deviation in the pathway. We performed factorial design analyses, with 
age as a covariate. Comparisons were done separately for the AMD 
group and its age-matched controls, and the JMD and its age-matched 
controls. Threshold-free cluster enhancement (TFCE) method were 
applied to minimize the need of large scale smoothing or of predefining 
the significant cluster size.  
3.3. Results
3.3.1. ROI-based findings
We first illustrate the distribution of the morphometric measurements in all 
ROIs for every group as boxplots (see Figure 1). 
Figure 1. Morphometric  comparisons of ROI located along the visual pathway, between the 
AMD, JMD, and their  respective age-matched controls. Boxplots show the median, the 25th and 
75th percentiles of all six  ROIs. Data were extracted from modulated normalized segments of T1-
weighted brain images. ROI - regions of interest; AMD - age-related macular degeneration; HCO - 
healthy controls (age-matched to AMD); JMD - juvenile type macular degeneration; HCJ - healthy 
controls (age-matched to JMD); pgcl - pregeniculate structures; lgb - lateral geniculate bodies; gcr - 
geniculocalcarine radiation; ocp - occipital poles;  icc - intracalcarine; scc - supracalcarine. 









In all ROIs, the controls have larger median volumes than the patient groups 
(AMD or JMD). Table 2 describes the mean morphometric values and the 
patient groups differences relative to their age-matched controls.   
ROI ! ± "!
pgcl (mm3) lgb (mm3) gcr (cm3) ocp (cm3) icc (cm3) scc (cm3)
AMD 401.58 ± 21.94 86.67 ± 3.17 9.51 ± 0.23 5.72 ± 0.12 3.46 ± 0.10 3.20 ± 0.10
HCO 459.41 ± 24.75 91.77 ± 3.02 11.29 ± 0.17 6.64 ± 0.12 4.11 ± 0.14 3.98 ± 0.16
JMD 382.62 ± 13.44 95.94 ± 3.48 10.78 ± 0.18 6.35 ± 0.11 3.99 ± 0.08 3.90 ± 0.08
HCJ 419.06 ± 12.64 109.76 ± 3.49 11.68 ± 0.19 6.95 ± 0.15 4.38 ± 0.13 4.19 ± 0.11
Relative difference to the controls (%) 
AMD -12.6 -5.6 -15.8 -13.9 -15.8 -19.6
JMD -8.7 -12.6 -7.7 -8.6 -8.9 -6.9
Table 1. ROI morphometry. Morphometric values in term of area or volume were extracted from along visual 
pathway. ROI - regions of interest; ! - mean; "! - standard errors of mean; AMD - age-related macular 
degeneration; HCO - healthy controls (age-matched to AMD); JMD - juvenile type macular degeneration; HCJ 
- healthy controls (age-matched to JMD); pgcl - pregeniculate structures; lgb - lateral geniculate bodies; gcr - 
geniculocalcarine radiation; ocp - occipital poles;  icc - intracalcarine; scc - supracalcarine. 
We also investigated the distribution of ROI volumes with regards to the 
distribution of age (Figure 2). In gcr and cortical ROIs, age seems to correlate 
negatively with the morphometric values. We therefore took the age as a 
covariate in our subsequent voxel-wise analyses. 
!
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Figure 2. Scatter  plots of the volume of ROIs along the visual pathway as against age. Data points 
were categorized into AMD, JMD, and their respective age matched controls. Morphometry were performed 
on modulated normalized segments of T1-weighted brain images. ROI - regions of interest; AMD - age-
related macular degeneration; HCO - healthy controls (age-matched to AMD); JMD - juvenile type macular 
degeneration; HCJ - healthy controls (age-matched to JMD); pgcl - pregeniculate structures; lgb - lateral 
geniculate bodies; gcr - geniculocalcarine radiation; ocp - occipital poles;  icc - intracalcarine; scc - 
supracalcarine.









Figure 3. Full visual pathway involvement in  AMD. The transversal slices of the template brain highlighted 
the areas where AMD group shows significantly lower cortical volume their age-matched controls (p<0.05, 
uncorrected). Involvement of the grey  matter can be seen in the visual cortex  (yellow), whereas white matter 
involvement can be seen in the optic tract and in region corresponding to the geniculocalcarine radiation 
(blue). The Talairach position of the slices are given as “z”. AMD - age-related macular degeneration. 
3.3.2. Voxel-wise findings
Voxel-wise statistics were done in the brain regions of the visual pathway. 
Figure 3 shows comparison between AMD patients and their age-matched 
controls, without correction for multiple voxels comparison.  Figure 4 shows 
comparison between JMD patients and their age-matched controls, without 
correction for multiple voxels comparison.
! In both types of macular degeneration, almost the whole retrobulbar 
afferent visual pathway structures are volumetrically lower than the healthy 
controls (p<0.05, uncorrected). The lateral geniculate bodies in AMD group 
however, did not show any statistically significant difference to its age-matched 
control. We then performed similar comparison, this time with small volume 
family-wise error correction. The result can be seen in Figure 5. 
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Figure 4. Full visual pathway involvement in JMD. The transversal slices of the template brain highlighted 
the areas where JMD group shows significantly lower cortical volume their age-matched controls (p<0.05, 
uncorrected). Involvement of the grey  matter can be seen in the visual cortex  and at the lateral geniculate 
bodies (green), whereas white matter involvement can be seen in the pregeniculate structures and in region 
corresponding to the geniculocalcarine radiation (red). The Talairach position of the slices are given as “z”. 
JMD - juvenile-type macular degeneration.
As can be seen in Figure 5, the full length of the visual pathway in JMD 
showed significantly lower volume than its age-matched controls (p<0.05, 
FWE-corrected). Whereas in AMD, the remaining significant lower volume of 
the pathway is only visible in the visual cortex and in the geniculocalcarine 
radiation (p<0.05, FWE-corrected).









Figure 5. The extent of visual pathway 
involvement in AMD and JMD. Smaller volume of 
the visual cortex  and the geniculocalcarine radiation 
in AMD vs HCO, but not the lateral geniculate 
bodies nor the pregeniculate structures, remain 
significant following small volume family-wise error 
correction for multiple voxels comparison. On the 
other hand, the full length of the pathway showed 
smaller volume in JMD vs HCJ, retaining their 
significance even after the similar correction. 
Statistical threshold: p<0.05, small volume FWE-
co r rec ted . AMD - age - re l a ted macu la r 
degeneration; HCO - healthy controls (age-matched 
to AMD); JMD - juvenile type macular degeneration; 
HCJ - healthy controls (age-matched to JMD).
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3.4. Discussion
Macular degeneration has been known as one of the primary cause of blindness and 
its ocular or retinal pathology has been studied extensively. The cerebral involvement, 
however, has been studied more only in the recent decade10,  12, 16, 19, 32-34. Our previous 
finding on the loss of grey matter density in AMD12, and visual pathway volumetric 
loss in glaucoma15 had raised further question on the (pre-cortical) volumetric 
condition of the visual pathway in macular degeneration. Here, we found that in 
macular degeneration, especially in the juvenile type, there was indeed volumetric loss 
of visual pathway structures. 
! While in primary open-angle glaucoma (POAG) it becomes intuitive to think 
that the retrobulbar visual pathway may be involved in its pathology, it may not 
necessarily be the case for macular degeneration. In the latter, the primary loss of 
retinal layer occurs due to the damage of photoreceptors, which are first order 
neurones. Therefore, any degeneration does not necessarily be translated across the 
retinal layers to the bipolar (second order neuron) and retinal ganglion cell (RGC, 
third order neuron) layers and their projecting axons, as suggested by Margalit et al.
35,  let alone the geniculate and post-geniculate structures. However, the loss of RGC 
may also be attributed to the loss of photoreceptors, as revealed by Medeiros and 
Curcio36  in wet AMD and Kim et al.37 in AMD in later stage of dry AMD 
(geographic atrophy). These showed that RGC is not free from the adverse effect of 
photoreceptors disruption. 
! When we plotted the means of all ROIs as depicted in Figure 1, the degree of 
volumetric defect as compared to the age-matched controls along  the visual pathway 
is almost similar in AMD and JMD.  However, Table 1 showed that the relative 
volume differences to the controls were greater in AMD group. The findings shown in 
Table 1 suggest that the volumetric loss is greater in AMD than in JMD.  Since by 
definition AMD is age-related,  we plotted the ROIs’  mean volumes against the age to 
see if there is any sort of correlation with the age. Indeed, negative correlation seemed 
to be present at the geniculocalcarine, occipital pole, intracalcarine, and 
supracalcarine regions. To account for this possible age effect, in the subsequent 
voxel-wise analyses, age was accounted for. When voxel-wise statistics were used, 
volumetric differences between JMD and the age-matched control group survived 
even more conservative statistical confidence thresholding. The discrepancy between 
ROI-based and voxel-wise findings may be explained by several following  reasoning. 
First, any individual value extracted from any ROI is a mean value over a sizeable 
ROI, which contained several to thousands of voxels. This practically made ROI-
based analyses somehow more coarse in nature, as opposed to the voxel-based one. 
Second, taking  age into account in the analyses became essential,  as one of the disease 
was explicitly age-related while the other was not. Therefore, ROI-based approach 
might underestimate the age effect.  Even when the visual cortex is one of the least 
age-affected compared to the rest of cerebral cortex, we believe it was a good practice 
to account for age-effect in the analyses of the human visual pathway. Juvenile-type 
macular degeneration starts earlier in life and thus the disease period is relatively 
longer,  hence there will probably be more chance that JMD affects the retrobulbar 
visual pathway than the AMD does in term of temporal aspect. Some studies had 
shown how brain is functionally affected by JMD11. But then again, structural 
involvement as we have reported earlier in this paper, as far as we know, have not 
been reported earlier. 









Our study design was cross-sectional, therefore we can not determine which 
happened first, the volumetric reduction in the brain,  or the degeneration in the 
macula. Nonetheless, considering the fact that macular degenerations have been 
mainly managed clinically as  ocular pathologies, the structural changes,  mainly in the 
LGB and the visual cortex, should alert clinicians on the possibility of brain-related 
mechanism involved in the disease. Neuroprotective approach to preserve the 
photoreceptors and retinal pigment epithelium by the administration of ciliary 
neurotrophic factors38 or anti-inflammatory39 drugs may be worthwhile to consider. A 
better comprehension of the pathology of various macular degeneration types and 
diagnostic approach are of utmost importance to allow the quantification of the 
treatment outcome. We believe that neuroimaging and retinal imaging40, as well as 
their quantification methods12, 22, 41, 42, would be a clinically viable option to evaluate 
the progress of the disease and the treatment outcome.
! In summary, we reported our visual pathway morphometric study on macular 
degeneration. In both types of macular degeneration (age-related and juvenile) the 
volume of the visual pathway was reduced. However, the extent of involvement was 
different for the two types of disease, the JMD being  the one with more widespread 
involvement of the visual pathway. These warrant the necessity of further 
investigation on the chronology of the visual pathway changes in macular 
degeneration. 
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This study aimed to establish whether primary open-angle glaucoma (POAG) is 
associated with a change in volume of the visual pathway structures between the 
eyes and the visual cortex. To do so, we used magnetic resonance imaging (MRI) in 
combination with automated segmentation and voxel-based morphometry (VBM). 
Eight patients with POAG and twelve age-matched controls participated in the 
study. Only POAG patients with bilateral glaucomatous visual field loss were 
admitted to the study. The scotoma in both eyes had to include the paracentral 
region and had to be at least partially overlapping. All participants underwent 
high-resolution, T1-weighted 3T MRI scanning. Subsequently, VBM was used to 
determine the volume of the optic nerves, the optic chiasm, the optic tracts, the 
lateral geniculate nuclei (LGN), and the optic radiations. Analysis of covariance 
was used to compare these volumes in the POAG and control groups. The main 
outcome parameter of the measurement was the volume of visual pathway 
structures. Compared to the controls, subjects with glaucoma showed reduced 
volume (p<0.005) of all structures along  the visual pathway, including  the optic 
nerves, the optic chiasm, the optic tracts, the LGN, and the optic radiations. POAG 
adversely affects structures along the full visual pathway, from the optic nerve to 
the optic radiation. Moreover, MRI in combination with automated morphometry 
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In the developed world, glaucoma is one of the most notorious causes of visual field 
defects1. Typically, over the course of the disease the visual field becomes narrower, 
but foveal vision remains relatively intact. The pathogenesis of the disease is not well 
understood, which hampers early diagnosis and advances in treatment. 
! Degeneration of retinal ganglion cells (RGC) is currently thought to play a key 
role in the pathogenesis of glaucoma2-22.  The resulting damage to the RGC axonal 
projections2, 22-25  is reflected by thinning  of the retinal nerve fiber layer (RNFL)26. 
Analysis of RNFL thickness has thus become a primary tool for investigating 
volumetric changes in the most anterior part of the visual pathway27-37. Moreover, 
growing evidence suggests translation of the RGC degeneration to more distal parts of 
the visual pathway25, 38-41. In mice, the loss of RGC is followed by a reduction in 
thickness and area of the optic tract38. In non-human primates, an experimentally 
induced increase in intraocular pressure led to RGC loss and to the degeneration of 
the lateral geniculate nuclei (LGN) cell layers25. In humans, magnetic resonance 
(MR) imaging  studies have shown that patients with glaucoma, compared to healthy 
individuals, have smaller optic nerves, a smaller optic chiasm40, and smaller LGN41. A 
diffusion tensor imaging (DTI) study found marked, disease stage correlated changes 
in the optic nerves and weak changes in the optic radiations when comparing 
glaucoma patients and healthy controls42. Finally,  the visual cortex was shown to 
decline in volume in glaucoma, as revealed in one post-mortem study by Gupta et al.43 
and in a recent in vivo MR study from our group44. The degeneration in these central 
portions of the visual pathway in humans might also be a sign of trans-synaptic 
neuronal degeneration, which is provoked by the death of the RGCs. 
! Thus far, MR-based measurements of the size of the human pre-cortical 
portion of the visual pathway have all been performed manually39-41, 45. Besides being 
time consuming, this manual assessment can result in subjective measurement bias. To 
overcome these disadvantages, in a recent study,  our group used an automated 
morphometric technique that can objectively compare anatomical changes at all 
locations in the brain simultaneously. Using  this new approach, we found MR 
evidence for grey matter density loss in the primary visual cortex in individuals with a 









long-standing  visual field defect due to primary open-angle glaucoma (POAG)44. 
This, together with the DTI findings mentioned earlier42,  implies that the optic 
radiation that carries visual information from the LGN to the visual cortex may also 
be affected in POAG.  To our knowledge,  morphological changes have not yet been 
reported for these structures. 
! If morphological changes in the visual pathway can be reliably measured, this 
could assist a clinician in deciding on the diagnosis, prognosis, and further 
management of individual patients. In the present study we investigated volumetric 
changes along the entire afferent visual pathway in individuals with POAG by using 
automated morphometric methods. Specifically, we addressed the following  research 
questions. (1) Compared to healthy controls, do subjects with glaucoma exhibit 
changes in the volume of the visual pathway? (2) If there is such a change,  does the 
change in volume correlate with changes in visual field sensitivity?
4.2. Methods
4.2.1. Subjects
This study conformed to the tenets of the Declaration of Helsinki and was 
approved by the medical review board of the University Medical Center 
Groningen (Groningen, the Netherlands). All participants gave their informed 
written consent prior to participation.
! Patients with POAG were recruited from participants in the Groningen 
Longitudinal Glaucoma Study46. Eight patients participated (one female and 
seven males; mean age 72 years old,  range 62-85 years old). The participant 
inclusion criteria were the following:  1) a glaucomatous visual field defect of at 
least 10 degrees in diameter in at least one quadrant, affecting both eyes;  2) 
these visual field defects had to include the paracentral regions in both eyes; 3) 
these defects had to have been present for at least three years. The severity of 
the visual field loss was determined by the mean deviation (MD) scores; 
Humphrey Field Analyzer (Carl Zeiss Meditec AG, Jena, Germany). Table 1 
lists the characteristics of the patients. Patients with any other ophthalmic or 
neuro-ophthalmic disease that might affect the visual field were excluded. Table 
1 lists these characteristics.
! For the control group, 12 healthy age-matched subjects (three females 
and nine males; mean age 67 years,  range 61-83) were recruited. They were 
recruited from among  the partners and unrelated acquaintances of the visual 
field impaired participants or via advertisements in a local newspaper. Control 
subjects were required to have good best-corrected visual acuity (logMAR!0), 
not to have any visual field defect (according to the Groningen Longitudinal 
Glaucoma Study)46 and to be free of any ophthalmic, neurologic, or general 
health problems. Detection of an abnormal visual field 
is explained in the Perimetry section below.
! This study involved participants reported in another study44; the 
participants of our present study are the same as those listed in the POAG 
group in that study; the healthy controls in that study were also the same. The 
present study used the same MRI scans as those used in the prior study44, but 
addressed volumetric changes along  the visual pathway, rather than being 




The visual field was tested with the Humphrey Field Analyzer (HFA; 
Carl Zeiss Meditec AG, Jena, Germany). A standardized method for 
examining the central visual field up to 30 degrees eccentricity, the 30-2 
Swedish Interactive Threshold Algorithm (SITA)-Fast, was employed. 
A visual field defect was considered to be present if one of the the 
glaucoma hemifield test is outside of the normal limit, or if the pattern 
standard deviation’s p is less than 0.05, or if if there were at least three 
adjacent non-edge points (with p<0.05) in the pattern deviation 
probability plot, with at least one point having a p-value less than 0.0147. 
This defect had to be present on at least two consecutive, reliable tests in 
the same region of the visual field (not including the first visual field 
measurement ever made).  A test result was considered unreliable if false 
positive catch trials exceeded 10%, or if both false negative catch trials 
and fixation losses exceeded 10% and 20%, respectively. Moreover, 
deficits had to be compatible with glaucoma and have no other 
explanation.
4.2.2.2. T1-weighted image acquisition
All participants were scanned on the 3.0 Tesla MRI scanner (Philips 
Intera, Eindhoven, the Netherlands) located at the BCN Neuro-imaging 
Center of the University Medical  Center Groningen. For each 
participant, a high-resolution, T1-weighted, anatomical scan was made 
using magnetization sequence T1W/3D/TFE-2, 8 degrees flip angle, 
repetition time 8.70 ms, matrix size 256 x 256, field of view 230 x 160 x 
180, yielding 160 slices, and a voxel dimension of 1 x 1 x 1 mm. 
4.2.3. MR data analysis
The data analysis procedure involved the following  steps: image preprocessing, 
generation of study specific tissue probability maps (TPM), segmentation, 
registration, modulation of the segments, and finally a statistical comparison of 
differences in the volumes of different tissue segments between the POAG and 
control groups within the visual pathway. The process from the segmentation 
to the voxelwise statistical  analyses is known as voxel-based morphometry or 
VBM. We used the voxel-based morphometry (VBM) that is part of the SPM8 
software package (Wellcome Department of Imaging Neuroscience, London, 
UK; http://www.fil.ion.ucl.ac.uk/spm) to compare the volume of subcortical 
structures between the glaucoma and control groups48.  VBM statistically 
assesses local changes in grey and/or white matter volumes between groups of 
anatomical scans. The steps in the data analysis procedure are described in 
more detail below.
4.2.3.1. Image pre-processing
Several pre-processing  steps were performed on the scanned images 
before the actual measurement and statistical analyses. Image 
reorientation to the average image of all subjects’ brains was applied, to 









ensure registration of the images. 
4.2.3.2. Generating study-specific tissue probability maps
One problem was that the standard TPMs available in the SPM8 
software did not facilitate the detection of diencephalic nuclei, including 
the LGN. As a solution, we generated our own TPMs. TPM generation 
began by extracting the brains using the Brain Extraction Tool (BET)49, 
available within the FMRIB  Software Library (FSL; http://
www.fmrib.ox.ac.uk/fsl). Next, for the segmentation, we used the 
FMRIB Automated Segmentation Tool (FAST)50. However, instead of 
letting FAST segment the extracted brains into the standard three tissue 
classes (grey, white and cerebral spinal fluid (CSF)), we made it 
segment the brains into six tissue classes. Next, we created average 
tissue class images based on the data from all subjects from the POAG 
and the control groups.  After this, these average images were smoothed 
using a Gaussian kernel with a full-width half-maximum (FWHM) of 8 
mm. In the SPM8 segmentation, the sixth tissue class image was used as 
the TPM containing  the prior for the optic nerves,  chiasm, tracts and 
radiations. The fifth tissue class image was used as the TPM with the 
prior for the thalamus and other diencephalic nuclei. The 1st to 4th 
tissue classes were collated and used as the TPM with the prior for other 
brain tissues.
4.2.3.3. Segmentation, registration, and modulation
We used SPM8’s DARTEL (Diffeomorphic Anatomical Registration 
through Exponentiated Lie Algebra) suite of tools51, 52. In short, the 
DARTEL tools enabled us to create modulated grey and white matter 
images that were registered to a common reference image specifically 
representing  our sample, instead of registering them to a more general 
template,  such as the MNI (Montreal Neurological Institute) template 
that comes with SPM8. The study-specific method we used here enabled 
a more accurate inter-subject registration of brain images with improved 
localization and sensitivity of the VBM.
! The process began with SPM8‘s segmentation using  the TPMs 
we had created (as we explained in the paragraph above). After all the 
brains were segmented, a reference –or template– image was generated. 
The first step in generating this reference image was averaging the 
images of all brains. Following this, the individual brains were deformed 
and registered as closely as possible to this reference image. Next, using 
the registered brain images, a new average reference image was created 
to which the individual brain images were again registered. After 6 of 
these averaging and registration cycles, the final reference image was 
generated. The final reference image was then used as the template to 
which the native segmentations of the individual brains in the study 
were registered and modulated.
4.2.3.4. Smoothing
To increase the signal-to-noise ratio prior to statistical testing, we 
50
smoothed the segmented images using  a Gaussian kernel (FWHM = 4 
mm). 
4.2.3.5. Statistical testing 
Covariance analysis was used to examine between-group differences in 
the segments,  with age as a covariate. Statistical testing was restricted to 
the visual pathway.  The visual pathway was demarcated using  a mask 
that included the optic nerves up to the white matter regions where the 
optic radiations can be expected to be situated. The visual pathway 
mask was created manually, based on the average brain image from all 
participants. Regarding  statistical testing, no correction for multiple 
comparison was used, because we only compared the groups within a 
well-defined region (the visual pathway). Hence, our hypothesis was an 
anatomically-closed one and no further correction for overall brain 
volumes was necessary. 
! In addition to the VBM analysis,  we also performed a region-of-
interest (ROI)-based statistical analysis. For this analysis, we defined 
nine ROIs: the right optic nerve (RON), the left optic nerve (LON), the 
optic chiasm (OC), the right optic tract (ROT), the left optic tract 
(LOT), the right lateral geniculate nucleus (RLGN), the left lateral 
geniculate nucleus (LLGN), the right optic radiation (ROR), and the 
left optic radiation (LOR). The spatial variation in the position and size 
of the optic radiations is less uniform; this is why we defined a relatively 
large region of interest to capture the ROR and LORs in individual 
brains. Figure 1 shows these latter two regions of interest. In the ROI-
based analyses, statistical comparison was done using ANCOVA, with 
age as a covariate. 
Figure 1. Regions of interest defining the possible locations of the optic radiations. 
The optic radiation ROIs are shown on the reference brain image created for this study. The 
yellow ROI represents the right optic radiation, whereas cyan represents the left optic 
radiation. ROI = region of interest.











Patients’  characteristics are listed in Table 1. Statistical testing (Mann-Whitney 
U-test) revealed no significant difference in age between the glaucoma and 
control groups (p=0.13).
Characteristics Values
Age, median (range), years 72.5 (62 - 85)
Male sex, % 87.5
Family history of glaucoma, % 85.7
Visual acuity in logMAR, median (range) 0.1 (0.0 - 0.7)
IOP
       Highest ever recorded, median (range), mmHg 30 (17 - 55) mmHg
       Treated, median (range), mmHg 14 (12 - 16) mmHg
Visual field MD
        Right eye, median (range), in dB -11.62 (-5.23 to -27.20)
        Left eye, median (range), in dB -15.30 (-3.67 to -24.59)
Scanning laser polarimetry (GDx), the number
        Right eye, median (range) 63 (51 - 97)
        Left eye, median (range) 61 (38 - 95)
Scanning laser polarimetry (GDx) ellipse average thickness
        Right eye, median (range), !m 59 (45 - 69)
        Left eye, median (range), !m 62 (46 - 72)
Table 1. Baseline patient characteristics. Characteristics of the patients were age, sex  and positive family 
history proportion (in percentage), visual acuity for one or both eyes (expressed in logMAR), intraocular 
pressure (in mmHg), visual field sensitivity (expressed as MD in dB), nerve fiber indicator, and nerve fiber 
layer thickness (in !m). logMAR – logarithm of minimum angle of resolution; IOP - intraocular pressure; MD – 
mean deviation; dB – decibel; !m – micrometer.
We then used automated voxel-based morphometry to examine differences 
along  the visual pathway between the glaucoma and control groups. Figure 2 
depicts the region in the brain where the white matter volume is reduced in the 
glaucoma group as compared to the control group (thresholded at p<0.005, 
uncorrected). Significant reductions in volume are present bilaterally in the 
optic nerves, the optic chiasm, and in both optic tracts. 
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Figure 2. Reductions in volume along the pre-geniculate visual pathway in  glaucoma, as determined 
by using voxel-based morphometry. Highlighted structures (including the optic nerves, chiasm, and tracts) 
indicate regions with statistically significant volumetric reductions in subjects with glaucoma, compared to 
age-matched controls (thresholded at p<0.005, uncorrected). Lateral  geniculate nuclei  and optic  radiations 
are not shown in this rendering. 
The volumetric reductions extend beyond the optic tracts, but this cannot be 
observed in Figure 2. For this reason, Figure 3 shows a series of axial slices 
that allow examination of reductions beyond the optic tract.  









Figure 3. Axial slices indicating reductions in volume along the visual pathway in glaucoma, as found 
using voxel-based morphometry. Compared to the age-matched controls, subjects in the glaucoma group 
have a reduced volume of the pre-cortical visual pathway structures (Figure 3A-L). Statistically  significant 
volumetric reductions in the lateral geniculate nuclei are indicated by cyan arrowheads in Figure 3J and 3K. 
Statistically significant changes in the optic radiations are depicted in Figures 3I - L. Statistical maps are 
thresholded at a level of p<0.005 (uncorrected).
Compared to the age-matched controls, participants in theglaucoma group had 
a reduced volume of the pre-cortical visual pathway structures, as shown in 
Figure 3. Marked changes to the optic chiasm are visible in Figures 3F-H. 
Volumetric reductions in the lateral geniculate nuclei can be observed in 
Figures 3J and 3K, whereas changes in the optic radiations can be observed in 
Figures  3I-L. We repeated the VBM analysis using  TPMs based on an 
independent set of brains.  The results of this analysis were highly comparable 
to those reported above (see Supplementary Materials, http://www.iovs.org/
lookup/suppl/ doi:10.1167/iovs.10-5682/-/DCSupplemental). 
! Figure 4 shows boxplots for the ROI-based volumetric measurements 
for the individual subjects in control and glaucoma groups. Table 2 lists the 
individual subject’s volumes for each ROI, as well as the relative volume loss in 
each ROI. The final row of Table 2 lists the values related to the statistical 
comparison. 
! Table 2 and Figure 4 indicate that the ROI-based comparisons of the 
glaucoma and control groups showed significant volumetric differences in 
nearly all ROIs.  With exception of the left optic radiation, the glaucoma group 
had an overall lower volume along the full visual pathway.
54
Volume (mm3)
RON LON OC ROT LOT RLGN LLGN ROR LOR
CONTROL
Subject 01 74 123 44 368 499 135 134 8627 8127
Subject 02 80 99 35 371 526 137 127 10213 10510
Subject 03 79 135 32 374 481 132 142 11643 12580
Subject 04 92 148 50 448 599 174 162 12028 11910
Subject 05 93 128 16 371 584 173 160 11961 11944
Subject 06 67 151 40 421 541 149 141 12677 12935
Subject 07 125 138 58 477 630 156 160 11740 11906
Subject 08 103 121 40 427 551 133 121 10582 11006
Subject 09 102 149 52 428 564 159 154 10269 10864
Subject 10 112 149 58 434 568 171 206 11191 10108
Subject 11 107 144 34 489 660 144 121 11949 12316
Subject 12 102 165 54 402 536 156 136 11825 12225


















Subject 13 27 143 1 260 388 122 126 9159 10098
Subject 14 43 105 12 299 403 137 131 8675 7983
Subject 15 52 81 11 323 458 108 112 8504 8661
Subject 16 33 116 4 278 366 110 108 7333 7204
Subject 17 52 76 11 333 420 87 103 6211 6903
Subject 18 53 112 6 317 436 141 123 9555 10215
Subject 19 74 122 29 383 517 148 126 11591 12138
Subject 20 34 117 3 360 545 151 132 12304 12958
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Table 2. Comparison of volumetric  measurements in  ROIs along the precortical visual pathway in 
glaucoma patients and controls. ROI -  region of interest; RON - right optic nerve; LON - left optic  nerve; 
OC - optic chiasm; ROT - right optic tract; LOT - left optic tract; RLGN - right lateral geniculate nucleus; LLGN 
- left lateral geniculate nucleus; ROR - right optic radiation; LOR - left optic radiation; SD - standard deviation. 









Figure 4. Comparison of volumetric measurements in  ROIs along the precortical visual pathway in 
glaucoma patients and controls. Boxplots show  the average and 25th and 75th percentiles for nine ROIs: 
RON, LON, OC, ROT, LOT, RLGN, LLGN, ROR, and LOR (abbreviations are the same as those for Table 2). 
Data was extracted from the unsmoothed modulated segments of the T1-weighted brain images.
4.3.2. Correlation analyses
We determined the correlations between the binocular average of the mean 
deviation of visual field sensitivity (MD) and the volume of the ROIs described 
above. Table 3 shows that none of the correlations between the ROI volume 
and the MD of the glaucoma group reached statistical significance. The scatter 
plots in Figure 5 show relative volume change for individual patients as a 
function of the binocular average of the MD. 
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Region of Interest
RON LON OC ROT LOT RLGN LLGN ROR LOR
Mean deviation OD R=0.24; p=0.57 n/a - - - - - - -
Mean deviation OS n/a R=0.58; p=0.13 - - - - - - -
Binocular average of 















Table 3. Correlations between visual field sensitivity and volume of visual pathway structure in the 
glaucoma group. Abbreviations: MD - mean deviation (of visual field sensitivity); OD - oculus dexter (right 
eye); OS - oculus sinister (left eye); ROI - region of interest; RON - right optic nerve; LON - left optic  nerve; 
OC - optic chiasm; ROT -right optic tract; LOT - left optic tract; RLGN - right lateral  geniculate nucleus; LLGN 
- left lateral geniculate nucleus; ROR - right optic radiation; LOR - left optic radiation. 
4.4. Discussion
Our results show that in comparison to healthy controls, subjects with glaucoma 
exhibited significant reductions in the volume of the visual pathway including  the 
optic nerves, chiasm, tracts, LGN, and optic radiations. In subjects with long-standing 
POAG, volumetric reductions were therefore present in the visual pathway. Starting 
from the optic nerve, we found that the intraorbital and intracranial optic nerve 
volumes were markedly reduced in glaucoma. 
! These findings corroborate earlier reports on structural damage to these 
sections of the visual pathway38-40, 42. The volumetric reduction need not be 
symmetrical, as can be seen in Figure 1. The reduction was most prominent in the 
distal half of the right optic nerve and in the middle third of the left nerve. 
Nonetheless, when we lowered the statistical threshold (to p<0.05), we observed the 
presence of POAG-associated volumetric reductions along the entire length of the 
optic nerve.  This indicates that the shrinkage may occur anywhere along  the entire 
length of the optic nerve. 
! The volume of the optic chiasm and tracts was reduced in glaucoma as well 
(Figure 1). Shrinkage was present in the optic chiasm and along the full length of the 
optic tracts, corroborating  results from earlier studies40,  53. Since the latter two 
structures are a direct continuation of the optic nerves, these findings are perhaps less 
surprising. A more interesting neuro-ophthalmological finding  is that also the lateral 
geniculate nuclei (LGN) showed volumetric reductions in subjects with POAG. This 
corroborates an earlier report by Gupta et al.41,  who used manual measurements in 
their study. Our results also indicate that the optic radiations are adversely affected. 
This is more surprising, as the axonal projections in the optic radiations are not a 
direct continuation of the retinal ganglion cell layer (RGC) axons,  but are projections 
from LGN relay neurons that transmit the visual information to the visual cortex. The 
volumetric reduction of the optic radiations complements the grey matter density 
reduction in visual cortex44. 









Figure 5. Scatterplots of volume reduction in visual pathway structures as a function of binocular 
visual field sensitivity deviation. The volume reduction for individual  patients is expressed as a percentage 
compared to the average volume in control participants. Data was extracted from the unsmoothed modulated 
segments of the T1-weighted brain images. (abbreviations are the same as those for Table 2), dB - decibel.
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The volumetric reduction of the optic radiations is also related to the finding – based 
on diffusion tensor imaging  (DTI) – that these structures showed increased mean 
diffusivity and decreased fractional anisotropy in glaucoma patients42.  This DTI 
finding implied that the integrity of the optic radiation in glaucoma is compromised. 
Our T1-weighted imaging and VBM results indicated that there is also a reduction in 
the volume of this brain structure in glaucoma. For future assessment of structural 
changes in patients,  DTI and T1-weighted imaging appear to be techniques that 
provide distinct and complementary information. How these DTI and VBM results 
exactly relate to each other, as well as to disease severity, would require comparisons 
in the same group of patients. 
! The proportion of volume loss in the visual pathway ranges from 78% in the 
optic chiasm to 16% in the optic radiation. A trend in the data suggests that the 
glaucoma-associated volume reduction decreases the further away a structure is from 
the eye.  This would fit with the notion that that the pre-geniculate volumetric 
reduction is transmitted trans-synaptically to the LGN and beyond. Another 
explanation for the volume reduction could be a change in metabolic activity due to 
the lack of RGC input as previously shown in primate glaucoma54  and visual cortex in 
human glaucoma55. However, it is beyond the capacity of the VBM methodology to 
determine the exact mechanism underlying the volumetric reductions.
! For the control participants, our estimate of the average volume of the LGN 
(149 mm3) lies in between previous estimates based on a post-mortem, MRI-
registered histological investigation (182 mm3)56 and another post-mortem histological 
study (118 mm3)57.  The latter estimate is smaller than ours, but this may be due to 
shrinkage as a result of formalin fixation.  Our method measures volume of (parts of) 
segmented images, so that the specific choice of segmentation parameters may 
influence absolute size estimates. However, this equally affects the measurements in 
patients and controls. 
! In their combined MRI and histological study, Burgel et al.56  estimated the 
average size of the optic radiations in healthy individuals to be 6798 mm3.  In this case, 
we got a larger average optic radiation volume (11297 mm3). This larger estimate can 
be explained by us deliberately defining a relatively large region of interest to 
guarantee that we would capture the ROR and LORs of all the individual brains. In 
the future, DTI-guided segmentation of high-resolution anatomical images of the 
brain may allow extraction of the optic radiation in an automated manner and provide 
even more accurate in vivo volumetric measurements.
! Our analyses showed no significant correlation between the visual field 
sensitivity (MD) and the volume of the visual pathway structures (see Table 3 and 
Figure 5). There may be several methodological reasons for this. ROI-based analyses, 
as we used here, are a relatively coarse measure in comparison to the resolution 
offered by VBM. Future studies may explore the structure-function relationship in a 
finer,  voxel-wise manner. These could also consider using  more comprehensive visual 
field measurements (for example, the full SITA method) to enable a more precise 
determination of the relationship between the severity of the reduction in visual field 
sensitivity and the volume of the visual pathway. It may be possible to further improve 
on the methods we used here by fine-tuning the registration parameters so as to focus 
more on the visual pathway rather than the whole brain, before performing the 
statistical analyses. With such technical refinements to the present technique and the 
inclusion of more participants in various severity stages of glaucoma, it might become 
feasible to determine how far along the pathway damage is occurring  and perhaps 









even the time sequence of damage. Such could be done through either longitudinal 
studies or by finding patients for whom damage only extends to certain points along 
the pathway.
! Our study also showed that the combination of MRI and automated 
morphometry can detect changes in the volume of the visual pathway. Our study is 
the first to detect such changes simultaneously using fully automated VBM. Standard 
VBM is not very suitable for detecting changes in the subcortical sections of the visual 
pathway. Moreover, to the best of our knowledge, surface-based methods only allow 
investigation of cortical structures as well. To enable detection of subcortical 
volumetric changes, we slightly modified the standard segmentation protocol of SPM 
by increasing the number of tissue classes. This allowed better segmentation, 
especially of the optic radiations and the LGN. This enabled us to greatly improve our 
assessment of volumetric changes in these structures using VBM.
! The TPMs that we used incorporated all  the subjects from both groups in the 
study and in principle do not bias the results in any direction. To verify the validity of 
this assumption, we repeated our VBM analysis using  TPMs based on an independent 
set of brains. The results of this analysis are highly comparable to the one reported in 
the main paper (see Supplementary Materials,  http://www.iovs.org/lookup/suppl/ doi:
10.1167/iovs.10-5682/-/DCSupplemental). Using  TPMs based on the brains of the 
study participants has the advantage that it results in more accurate registration and 
improved VBM sensitivity. 
! Previous reports on structural changes in glaucoma have used different 
dimensions such as height, area, or thickness of the structures of interest as their 
outcome parameters39, 40, 45, 58. Often, these measures were determined manually. 
VBM, on the other hand, performs an automated statistical comparison of volume on 
a voxel-by-voxel basis, thus allowing an unbiased and comprehensive comparison. 
Moreover,  it has the ability to detect subtle differences that manual measurements 
may not be able to detect. 
! In the present study, we used VBM primarily for its power in performing 
group comparisons. However, we believe the method and its components could have a 
more widespread use. In a group comparison study, all  brain images and their 
derivative grey and white matter segments necessarily have to be normalized to allow 
any comparisons. However, one can always opt not to do so in order to simply obtain 
the derivative grey and white matter segments,  thereby preserving an individual’s 
brain shape. For example, a clinician could then use the white matter segment – which 
is virtually free from the other non-white matter brain tissue – to precisely measure 
the dimensions of the optic chiasm or the optic tracts. In this case, only the accurate 
segmentation abilities of the VBM method are used to improve the sensitivity of 
manual measurements.
! In our view, a fully automated VBM approach could also be applied at the 
individual patient level, although this would require further research and 
development. Based on a large number of images of normal, healthy brains, a 
normative database of templates for subjects of various ages could be created. 
Following  automated normalization and segmentation, the brain images of an 
individual patient, could be compared  – on a voxel-wise basis – to the appropriate 
normal template in the database. Deviant structures in the patient’s brain could be 
highlighted. Such measurements and visualizations could assist a clinician in deciding 
on the diagnosis, prognosis, and further management of an individual patient. 
Potentially, multivariate pattern classification techniques could be applied to improve 
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the sensitivity of such automated assistive measurements. In the long run, volume 
reduction and other MR based assessments could become additional indicators to 
assess glaucoma progress42.
! In the future, these new methods could also help to decide whether a vision 
rehabilitation program for a patient is worthwhile,  since a degenerated pathway may 
limit the efficacy of rehabilitation and training  programs59  and retinal prostheses60. 
Furthermore,  due to the potentially deteriorative effect of glaucoma, physicians may 
also need to consider the prevention of degeneration as a new goal. In addition to such 
clinical implications, our results indicate that the automated and objective procedure 
of VBM can be applied in future research on the visual pathway. Finally, the present 
approach need not be restricted to the realms of neuro-ophthalmology. Automatic 
detection of changes in subcortical structures may also be useful in neurological or 
psychiatric disorders. 
! In summary, compared to healthy individuals, glaucoma patients show the 
presence of volumetric reductions which may extend all  the way from the optic nerve 
to the optic radiations.  Glaucoma, besides affecting  the eye and optic nerves, may thus 
also impact the central visual system. Despite the marked changes observed in pre-
geniculate structures of the visual pathway, more data  is needed, however, to 
ascertain the extend of the optic radiations involvement. 
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This study aims to find if there is any structure-function correlation between the 
visual pathway structures volume and the visual field sensitivity in primary open-
angle glaucoma (POAG). Seventeen subjects with varying stage of POAG 
voluntarily participated in the study. Only POAG patients with a minimum of three 
years of established diagnosis were included. The visual fields were taken with 
automated static perimetry to obtain the mean deviation (MD) of the visual field 
sensitivity. Magnetic resonance (MR) brain diffusion tensor imaging (DTI) and 
anatomical T1-weighted (T1W) imaging of all subjects were acquired on a 3T MR 
scanner. T1W images were processed to allow for volume measurement. Diffusion-
weighted (DW) image processing were done to obtain fractional anisotropy (FA) 
maps. Both T1W- and DW-derived images were eventually subjected to voxel-wise 
analyses to compare the brains in voxel-to-voxel manner. Structure to structure 
comparison was approached with regions-of-interest (ROI) based analyses. Voxel-
wise analyses revealed that the MD was correlated with pregeniculate  (p<0.05, 
FWE-corrected) and LGB volumes (p<0.05, uncorrected). ROI-based analyses 
showed only the pregeniculate volume was moderately correlated with MD 
(R=0.65; p<0.05, Bonferroni-corrected). Voxel-wise analyses showed that FA was 
correlated with MD (p<0.05, uncorrected) in geniculocalcarine region. ROI-based 
analyses failed to show any correlation between FA and MD. In summary, visual 
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Glaucoma has been a major interest of study in ophthalmology due to its prevalence 
and the potentially devastating  effect to the sufferers1, 2. Because of the visual 
impairment it causes,  the sufferer may experience decrease in the quality of life with 
extensive implications, e.g. psychologically, socially, and economically. Efforts to 
manage the condition have been resulting in countless studies on the pathology and 
treatment of glaucoma. 
! In recent years, studies on the effects of glaucoma on the brain have yielded 
many reports indicating  the involvement of the visual pathway in glaucoma3-11. Brain 
imaging showed that primary visual cortex 4,  9, 12, lateral geniculate bodies (LGB)3, 5,  10, 
12-15 and pregeniculate structures3, 10,  16  are affected by the disease. The structural 
studies reported employed diverse methods, ranging  from manual measurement5  to 
automated morphometry3,  4 of the structures of interest. They were performed mainly 
on histologic slice as a postmortem examination, and also on the high resolution 
anatomical acquisition (T1- and T2-weighted imaging). Advance in magnetic 
resonance imaging  have brought forward diffusion-weighted acquisition, and this 
opens possibilities to investigate more properties of the visual pathway structure6, 16. 
Earlier methods of,  for example voxel-based morphometry (VBM), already enabled 
researchers to investigate the visual pathway volume with less subjective bias. Using 
diffusion-weighted imaging, researchers are now able to infer the integrity of the 
visual pathway white matter structures in addition to the volumetric measurement 
derived from T1-weighted scans. 
! Our previous study has shown lower volumetric measurement of the human 
visual pathway in subjects with primary open-angle glaucoma or POAG, from the 
optic nerve to the visual cortex,  as compared to healthy subjects3, 4. The studies were 
mainly based on VBM of high resolution T1-weighted imaging of human brain. They 
were aimed at studying the visual pathway structures in the presence of homonymous 
visual field defects. With regard to patient management, a clinically relevant question 









would be whether there is any relationship between glaucoma severity and the visual 
pathway structures. Based on anatomical (T1-weighted) and diffusion-weighted 
imaging analyses, we hope to answer this question.
5.2. Methods
5.2.1. Subjects
This study conformed to the tenets of the Declaration of Helsinki and was 
approved by the medical review board of the University Medical Center 
Groningen (Groningen, the Netherlands). All  participants gave their written 
informed consent prior to participation.
! Patients with POAG were recruited from participants in the Groningen 
Longitudinal Glaucoma Study17.  Seventeen patients participated (eight females 
and nine males; mean age 63 years old, range 42-71 years old). The participant 
inclusion criteria were the following:  1) a glaucomatous visual field defect of at 
least 10° in diameter in at least one quadrant, affecting both eyes 
homonymously; 2) these visual field defects had to include the paracentral 
regions in both eyes; 3) these defects had to have been present for at least three 
years. The severity of the visual field loss was determined by the mean 
deviation (MD) scores as assessed with a Humphrey Field Analyzer (Carl 
Zeiss Meditec AG, Jena,  Germany). Table 1 lists the characteristics of the 
patients.  Patients with any other ophthalmic or neuro-ophthalmic disease that 
might affect the visual field  or visual acuity were excluded.   
5.2.2. Data acquisition
5.2.2.1. Perimetry
The visual field was tested with the Humphrey Field Analyzer (HFA; 
Carl Zeiss Meditec AG, Jena, Germany). A standardized method for 
examining the central visual field up to 30° eccentricity, the 30-2 
Swedish Interactive Threshold Algorithm (SITA)-Fast, was employed. 
A visual field defect was considered to be present if at least one of these 
criteria was present: glaucoma hemifield test outside of the normal limit, 
or the pattern standard deviation’s p less than 0.05, or at least three 
adjacent non-edge points (with p<0.05) in the pattern deviation 
probability plot on the same side of the horizontal meridian, with at least 
one point having  a p-value less than 0.0118. Defects had to be present on 
at least two consecutive,  reliable tests in the same region of the visual 
field (not including  the first visual field measurement ever made). A test 
result was considered unreliable if false positive catch trials exceeded 
10%, or if both false negative catch trials and fixation losses exceeded 
10% and 20%, respectively. Moreover,  defects had to be compatible with 
glaucoma and were not allowed to have any other explanation. The 
outcome measure used in this study was the MD.
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Characteristics Values
Age, mean (range), years 61 (42 - 71)
Male sex, % 64
Family history of glaucoma, % 29
IOP
       Highest ever recorded, mean (range), mmHg 32.6 (20 to 50)
       Treated, mean (range), mmHg 15.0 (10 to 20)
Visual field MD
        Right eye, mean (range), in dB -11.3 (-29.9 to 0.0)
        Left eye, mean (range), in dB -9.1 (-30.5 to -0.8)
Scanning laser polarimetry (GDx) NFI
        Right eye, median (range) 63.9 (44 to 83)
        Left eye, median (range) 49.2 (18 to 79)
Scanning laser polarimetry (GDx) ellipse average thickness
        Right eye, mean (range), !m 60.0 (51 - 84)
        Left eye, mean (range), !m 66.8 (51 - 102)
Table 1. Baseline patient characteristics. Characteristics of the patients were age, sex  and positive family 
history proportion (in percentage), intraocular pressure (in mmHg), visual field sensitivity (expressed as MD in 
dB), nerve fiber indicator, and nerve fiber layer thickness (in !m). logMAR – logarithm of minimum angle of 
resolution; IOP - intraocular pressure; MD – mean deviation; dB – decibel; NFI - nerve fiber indicator; !m – 
micrometer. 
5.2.2.2. Neuroimaging
All participants were scanned on the 3.0 Tesla MRI scanner (Philips 
Intera, Eindhoven, the Netherlands) located at the BCN Neuro-imaging 
Centre of the University Medical  Centre Groningen. For each 
participant, a high-resolution, T1-weighted, anatomical scan was made 
using magnetisation sequence T1W/3D/FFE, repetition time 25 ms, 
resolution 256 !  256, field of view 256 !  160 !  204, yielding  160 slices, 
and a voxel dimension of 1 ! 1 ! 1 mm. 
" We also acquired two 60-direction gradient diffusion-weighted 
(DW) images for every subject.  The first DW scan was made using 
DwiSE technique, resolution 128 x 128, APP fat shift 11.722 pixels, 
degree of angulation 0.57 1.405 -15.9, repetition time 5485 ms, field of 
view 240 !  102 !  240, echo time 79 ms, diffusion b value 800,  EPI 
factor 45, and voxel dimension 1.875 !  1.875 !  2.000 mm. The second 
DW scan has similar parameters as the first, except for APA fat shift 
12.035 pixels and repetition time 5516 ms. 
5.2.2.3. T1-weighted image processing and analyses
We defined six regions-of-interest (ROIs) along  the visual pathway: 
pregeniculate structures (pgcl), lateral geniculate bodies (lgb), 
geniculocalcarine radiation (gcr),  occipital pole (ocp), the intracalcarine 
(icc) and supracalcarine regions (scc). For the first two ROIs, the brain 
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images were cropped so that the desired ROI is captured while 
minimising  outside-of-ROI structures. For gcr, the registration is 
performed globally (using  the whole white matter of the brains) for the 
structure is not easily visually separable from the surrounding white 
matter. Only in the following statistical testing, we applied a mask 
derived from Jülich probabilistic atlas19, 20  to extract the 
geniculocalcarine radiation. For the last three ROIs, the occipital lobes 
of the brains were cropped and used. The image processing  involved the 
following  steps:  rigid-body registration, segmentation, registration,  and 
modulation of the segments. The process from the segmentation to the 
voxelwise statistical analyses is known as voxel-based morphometry 
(VBM). We used SPM8 software package (Wellcome Department of 
Imaging Neuroscience, London, UK; http://www.fil.ion.ucl.ac.uk/spm) 
to implement the VBM21.  The steps in the data analysis procedure are 
described in more detail in the following sections. 
5.2.2.3.1. Image pre-processing
A number of pre-processing  steps were performed on the scanned 
images prior to actual measurement and statistical analyses. 
Image reorientation to the average image of all subjects’ brains 
was applied to ensure registration of the images.
5.2.2.3.2. Segmentation, registration, and modulation
Commonly used registration methods allowed sufficiently good 
registration of the brain. Since we are interested in certain 
structures only, i.e. the visual pathway, we only registered the 
structures constituting the pathway. This way we improve the 
registration of the structures of interest. To do this, after 
registering the brain as a whole, depending  on the structures of 
interest, we registered the brains locally. For the pregeniculate 
structures (the optic nerve, chiasm, and tract), we masked the 
brains of the subjects so to isolate the pregeniculate structures 
and their surrounding only. Next, we aligned the pregeniculate 
structures to one another. The same is true for the LGB and the 
primary visual cortex. These were done prior to performing  the 
following steps described below.
! We then used SPM8’s DARTEL (Diffeomorphic 
Anatomical Registration through Exponentiated Lie Algebra) 
suite of tools 22, 23. In short, the DARTEL tools enabled us to 
create modulated grey and white matter images that were 
registered to a common reference image specifically representing 
our sample, instead of registering them to a more general 
template,  such as the MNI (Montreal Neurological Institute) 
template that comes with SPM8. The study-specific method we 
used here enabled a more accurate inter-subject registration of 
visual pathway structures with improved localization and 









The process began with SPM8‘s segmentation using  the TPMs 
we had created (as we explained in the paragraph above). After 
the entire visual pathway were segmented, a reference –or 
template– image was generated. The first step in generating  this 
reference image was averaging the images of all structures of 
interest. Following this, the individual structures of interest were 
deformed and registered as closely as possible to this reference 
image. Next, using the registered structures of interest images, a 
new average reference image was created to which the individual 
structures of interest images were again registered. After 6 of 
these averaging and registration cycles,  the final reference image 
was generated. The final reference image was then used as the 
template to which the native segmentations of the individual 
structures of interest in the study were registered and modulated.
5.2.2.4. Diffusion-weighted image processing and analyses
As DW acquisition is usually affected by the occurrence of eddy 
current,  its correction were done for both DW images. The correction 
procedure was implemented in the FSL. Distortion due to water-fat 
susceptibility were done using a MATLAB  script implemented by J.A. 
Farrell24. The diffusion tensor estimation were done using DTIFIT tool 
implemented in FSL. This created images of the first, second, and third 
eigenvalues, as well as their fractional anisotropy (FA) image derivative. 
The FA is obtained using the formula: 
where ,  !1, !2, !3  being the 1st, 2nd,  and 3rd  principal eigenvalues, 
respectively; and  Dav being the average of the three eigenvalues above. 
! We used a portion of SPM8’s DARTEL (Diffeomorphic 
Anatomical Registration through Exponentiated Lie Algebra) suite of 
tools 22, 23 to create images that were registered to a common reference 
image specifically representing  our sample, instead of registering  them to 
a more general template that comes with SPM8. The study-specific 
method we used here enabled a more accurate inter-subject registration 
of brain images with improved localization and sensitivity of the VBM. 
The first step in generating  this reference image was averaging  the FA 
images of all brains. Following  this, the individual FA images were 
deformed and registered as closely as possible to this reference image. 
Next, using  the registered FA images, a new average reference image 
was created to which the individual FA images were again registered. 
After 6 of these averaging and registration cycles, the final reference 
image was generated. The final reference image was then used as the 
template to which the native FA image of the individual subjects in the 
study were registered.
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5.2.3. Statistical analyses
We performed two type of analyses: (1) region-of-interest or ROI-based 
analysis;  and (2) voxel-wise analyses. In ROI-based analysis,  we use masks to 
extract the ROI volumes or mean FA.  The  ROI volumes were extracted from 
modulated normalised brain segments. While in voxel-wise analyses, we 
compared the brains voxel by voxel along the visual pathway. 
! As we had mentioned earlier, the six ROIs we compared are pgcl, lgb, gcr, 
ocp, icc, and scc.  The masks used to extract the volume of the pregeniculate 
structures and the lateral geniculate bodies were manually made by the 
investigator, for the boundaries of those structures are feasible to define 
visually. The mask for the geniculocalcarine radiation for volumetric analyses 
were derived from Jülich histological atlas 19, 20, whereas the mask for the 
occipital pole, intracalcarine and supracalcarine regions were derived from 
Harvard Center for Morphometric Analysis. 
! The second analysis is VBM, in which we correlated the images voxel 
by voxel along the visual pathway.  The method made it possible for  the 
investigators to spatially detect any deviation in the pathway. Threshold-free 
cluster enhancement (TFCE) method was applied to minimize the need of 
large scale smoothing  or of predefining  the significant cluster size. We 
performed factorial design analyses, with age as a covariate.  
5.3. Results
5.3.1. ROI-based findings
We extracted the values from every ROI, both for volumetric and anisotropy 
analyses.
5.3.1.1. Volumetric analysis
We extracted the volumes from all ROIs and perform correlation and 
regression analyses  with the MD. There is not any significant 
correlation between the MD and the ROIs volume along the pathway, 
except for the pregeniculate structures, where there is a positive 
correlation (R=0.65; p<0.05, Bonferroni-corrected) between the volume 
and the MD value. Linear regression of a model in which the MD being 
the dependent variable, while all ROIs volume and age were the 
predictors revealed an R2=0.75 (F=3.95; p=0.029), and the volume of pgcl 
being  the only significant predictor (T=4.08; p=0.0027). Figure 1 shows 
the MD values against the volume of the ROIs. 
5.3.1.2. Anisotropy analysis
From DW images, we extracted the mean FA values from the 
pregeniculate structures and the geniculocalcarine radiation. We plotted 
these values against the MD value.  We found no significant correlation 










Figure 1. Scatter  plot of structure-function relationship in the visual pathway structures. The x-axis is 
the volume of the visual  pathway structures and the y-axis is the visual  field mean deviation of sensitivity. 
There is a significantly positive correlation between the volume of pregeniculate structures and the mean 
deviation(R=0.65; p=0.005). dB - decibel; pgcl - pregeniculate structures; lgb - lateral  geniculate bodies; gcr - 
geniculocalcarine radiation; ocp - occipital poles;  icc - intracalcarine; scc - supracalcarine.
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Figure 2. Scatter  plot of fiber  anisotropy-function correlation in the visual pathway structures. The x-
axis is the FA of the visual pathway structures and the y-axis is the visual field mean deviation of sensitivity. 
There is no significant correlation between the FA and the MD (p<0.05). dB - decibel; FA - fractional 
anisotropy; pgcl - pregeniculate structures; gcr - geniculocalcarine radiation. 
5.3.2. Voxel-wise findings
5.3.2.1. Volumetric analysis
Figure 3 shows the visual pathway structures volume correlation with 
the mean deviation of visual field sensitivity.   The optic nerves, chiasm, 
tracts volume, as well as the volume of the lateral geniculate bodies, are 
correlated significantly (p<0.05, uncorrected) with the MD value. More 
conservative statistical thresholding left the pregeniculate structures 
volume still significantly correlated with the MD (p<0.05, FWE-
corrected). The strength of correlation was presented  earlier in the 
ROI-based analyses.
5.3.2.2. Anisotropy analysis
Figure 4 shows the visual pathway structures FA correlation with the 
mean deviation of visual field sensitivity. Only geniculocalcarine 
radiation’s FA was correlated significantly (p<0.05, uncorrected) with 
the MD. Pregeniculate structures failed to show any significant 
correlation with MD value. No structures survived more conservative 









Figure 3. Structure-function correlation in the visual pathway structures. The axial planes were from 
Talairach plane of z -7 mm down to z -23 mm to visualize the optic nerves, chiasm, tracts, lateral  geniculate 
bodies, and the geniculocalcarine radiation. The red shading shows where in the white matter of the visual 
pathway, the MD of the visual field is correlated significantly with the volume of the structures. The blue 
shading shows correlation of the volume of the lateral geniculate bodies to MD. Threshold is at p<0.05, 
uncorrected. MD – mean deviation.




Figure 4. Anisotropy-function correlation in  the visual pathway structures. The axial planes were from 
Talairach plane of z -11 mm down to z -10 mm to visualize the geniculocalcarine radiation. The green shading 
shows where the MD of the visual field is correlated significantly (p<0.05, uncorrected) with the FA value of 
the structures. The pregeniculate structures’ FA showed no significant correlation with the MD, hence the 












In our earlier studies3, 4, we found that the visual pathway structure in POAG patients 
are smaller than the healthy controls. The question is, if there is any relationship 
between the structures and the visual field sensitivity. This report is an effort to try 
answering this question. 
! In this study, we modified the standard VBM approach. In standard VBM, 
image processing  is done to the whole brain, thus, any registration and segmentation 
were based on global brain voxels information. What we did here was,  instead of 
processing  the whole brain, we processed the brains according to the structures of 
interest, i.e. the visual pathway. This was done with the purpose of achieving a better 
registration of the structure of interest. For example, first we performed a series of 
registration and segmentation (DARTEL) on the pregeniculate structures.  In doing 
so, we practically disregard the other parts of the brain and only use information from 
the voxels constituting the structures and their immediate surroundings. Better 
registration and spatial localisation can then be expected, and voxel-wise statistical 
inference can be more confidently made. 
! We discovered that there is a moderate yet very significant correlation between 
the MD and pregeniculate volume (p<0.05, corrected), similar to what Kashiwagi et 
al25. had found up to the optic chiasm. The apparently linear correlation between the 
MD and the pregeniculate structures might be due to the loss of RGC already in the 
early stage of the disease11, and throughout the later stages, with 5 dB  loss 
corresponds to 20-25% of RGC loss26, 27. In addition, a loss of 40% of RGC within the 
central 30° of the retina corresponds to 10 dB  decrease in sensitivity27. Since the optic 
nerve, chiasm, and tracts are all basically a continuous structure, the whole 
pregeniculate structures size should have a linear relationship with the optic nerve 
fibre count. Even though the volumes of the pregeniculate structures are linearly 
correlated with visual field sensitivity, this does not necessarily mean that there is also 
a linear correlation between the volumes of the LGB and beyond with the visual field 
sensitivity. Perhaps the LGB  and the geniculocalcarine radiation structures have some 
non-linear relationship with the visual field sensitivity. Or perhaps their structure-
function correlation measurable only in more severe stage of the disease. We can only 
speculate at this stage.  
! From anisotropy analyses, we found that the geniculocalcarine radiation’s FA 
(and not the pregeniculate’s FA) was correlated with the MD. Since the MD values 
can be related to the condition of the RGC and RNFL28, 29,  and since the 
pregeniculate structures are the continuation of RNFL, the structure-function 
correlation at the structures might be expected. Yet, FA analyses failed to show it. 
One of possible sources of the discrepancy is the difference of resolution acquisition. 
As had been described in the methods section, the T1W acquisition is of 1mm "  1mm 
"  1mm voxel size, whereas the on of the DW is 1.875mm "  1.875mm "  2mm. The 
difference may affect the sensitivity of the statistical testing  simply because of smaller 
number of data points in the DWI. Another possible source of discrepancy is the fact 
that the two acquisition, T1W and DW, gave us different images. The pregeniculate 
structures seen on a T1W image, visualised the structure with both the bundle of 
axons and the encapsulating  dura. The DW image on the other hand, showed the 
degree of signal changes due to water molecule displacement along the bundle of 
axons. Smaller size of the pregeniculate structures might be due to generalised 
reduction in all components of the structures: the axons,  the myelin, and the 
interstitial space. Due to this generalised shrinkage, the concentration (and the 
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anisotropy) of the water inside the structure might be preserved, leading  to relatively 
similar FA values between the subjects of different severity. Histological approach 
may be necessary to test whether the second possibility is true. 
! In summary, we found that there was a very significant and moderately strong 
relationship between the volume of the pregeniculate portion of the visual pathway 
and the visual field sensitivity.  The LGB and their geniculocalcarine projections 
showed at least a correlation trend with the visual field sensitivity. Based on what we 
have discovered so far from this study and from our earlier reports3, 4,  we argue that 
glaucoma management really need an integrated approach from neurology and 
ophthalmology standpoints. The retrobulbar pathway involvement in this POAG 
implicate the necessity of more attention toward keeping  the well-being of the neurons 
along  the entire visual pathway. This is particularly important when in the long term, 
the declining visual function may be easier to fix (although perhaps only partially) if 
the neuronal components are still preserved. Neuroprotective approach should 
perhaps really be considered in the management of patients with glaucoma, or neuro-
retinal diseases in general.
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The research reported in this thesis has resulted in several findings as well  as 
modifications of methodologies.   These have implications for our understanding  of the 
diseases studied and the future approach to dealing with the diseases. The following 
sections summarise and integrate these findings and methods to reach a final 
conclusion.*
6.1. Brief summary of the experimental studies
The findings and methods from each experimental chapter are briefly summarised 
below.
6.1.1. Grey matter density in visual field defects (Chapter 2)
The voxel-based morphometry (VBM) approach, as implemented in SPM5 
(Statistical Parametric Mapping version 2005),  was used to compare a group of 
subjects with age-related macular degeneration (AMD) and a group of subjects 
with primary open-angle glaucoma (POAG) to a group of age-matched 
controls. Regardless of the disease, all patients had homonymous visual field 
defect. The defects in the visual fields were mainly central (foveal or macular) 
in AMD and peripheral in POAG. We found low cortical grey matter density 
in the occipital lobe in both patient groups. In the AMD group, low grey 
matter density was found in the posterior half (or approximately at the occipital 
pole) of the calcarine cortex, whereas in the POAG group, this low density was 
found in the anterior half. The localisation was roughly retinotopic. This might 
indicate the presence of structure-function relationship at the level of the 
primary visual cortex. 
6.1.2. Visual pathway morphometry in macular degeneration 
(Chapter 3)
The loss of cortical grey matter density in AMD and POAG prompted the 
exploration of both cortical and precortical portions of the visual pathway. We 
studied two types of macular degeneration: the age-related type (AMD) and 
the juvenile-type (JMD). Participating  in this study were 113 subjects from 
York (United Kingdom), Regensburg (Germany) and Groningen (the 
Netherlands). We modified the registration process in VBM to allow 
structures-of-interest (SOI)-based morphometry. Applying  both DARTEL 
(Diffeomorphic Anatomical Registration through Exponentiate Lie Algebra) as 
implemented in SPM8 (SPM version 2008) and our own modification of this 
software,  we were able to improve the selective registration of the structures 
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*  The first section of this chapter is about the experimental studies, which were collaborative efforts, 
therefore the first person plural forms are used. The second and third sections were the opinion of the 
thesis’ author, therefore the first person singular forms are used.
constituting the visual pathway, instead of relying  on the registration of the 
whole brain. Comparing the patient groups against age-matched controls, we 
discovered that volumetric reductions were present over the full length of the 
visual pathway, from the optic nerve to the visual cortex. The differences were 
most pronounced in JMD. We postulate that the relatively longer disease 
period in JMD may cause this. While previous studies have reported how 
visual cortex functions are reduced in macular degeneration, to our knowledge 
ours was the first study to show that the visual pathway anatomy is adversely 
involved in the disease.
6.1.3. Visual pathway morphometry in glaucoma (Chapter 4)
The research reported in this chapter explored the precortical portion of the 
visual pathway structure involvement in glaucoma, which was similar to the 
previous chapter on macular degeneration. We modified the segmentation in 
SPM8, enabling  us to better extract the lateral geniculate bodies (LGB), by 
changing  the tissue probability maps. After applying DARTEL as discussed in 
the previous chapter, we found that POAG subjects had low volumetric values 
in the optic nerves,  chiasm, tracts, the LGB  and at the geniculocalcarine 
radiation. This neuroimaging study was corroborated by post-mortem findings 
as well as DTI (diffusion tensor imaging)-based findings from other groups. In 
addition, this result confirmed the finding of density changes in the visual 
cortex in glaucoma as reported in Chapter 2. 
6.1.4. Visual pathway and glaucoma severity (Chapter 5)
In the previous chapter, we showed that when the visual cortex density was 
low, the volume of the precortical portion of the visual pathway was also low. 
This led us to explore how the severity of the visual field defect may correlate 
with the anatomy of the pathway. In this chapter, we presented findings using 
volumetric and anisotropy analyses in glaucoma patients. The voxel-wise 
statistics were based on the same registration approach described in Chapter 3. 
In the early portion of the pathway (the pregeniculate structures), the volume 
of the structures was associated with the mean sensitivity of the visual field. 
Moreover,  at the postgeniculate level,  we found low integrity (indicated by 
fractional anisotropy or FA) of the geniculocalcarine radiation.  In accordance 
with the results in Chapter 4, we postulate that a visual field defect in glaucoma 
patients has a negative effect on the entire visual pathway, instead of being 
restricted to retinal ganglion cell loss alone. 
6.2. General discussion of the findings
The retrobulbar and intracranial part of the human visual pathway consists primarily 
of third and fourth order neurons. At the same time, the second order neuron (the 
bipolar cell) is located inside the retina of the eye. My studies focussed on macular 
degeneration and glaucoma. These diseases affect the photoreceptors and the retinal 
ganglion cells (RGCs), respectively.  Accordingly, clinical management of the diseases 
has focussed on the eye.  My main research question was whether these ocular 
pathologies, with their associated visual field defects, affect the integrity of the visual 
pathways leading to the visual cortex. The findings presented in this thesis may 










! As mentioned in the preceding chapters,  reports have been published on how 
the primary visual cortex functions differently – less effectively – in cases of macular 
degeneration and glaucoma. As long as the visual cortex is viewed as only functionally 
representing  the stimuli that the retina is able to process, such functional differences 
are expected and are not surprising. Consequently, the decreased function is not 
necessarily caused by degenerative changes in the cortex itself;  after all, the primary 
visual cortex is a processor of visual stimuli. However, our studies indicate otherwise. 
The visual pathway of individuals with macular degeneration or glaucoma were 
morphometrically smaller, and were not structurally similar to those in healthy brains.
! First, I found that the pregeniculate structures – the optic nerve, chiasm and 
tract – were significantly smaller in subjects with glaucoma or macular degeneration. 
It is relatively easy to see why this would be the case with glaucoma, but not with 
macular degeneration. RGC loss and the retinal nerve fibre layer (RNFL) thinning in 
glaucoma mean that the number and/or size of the axons have decreased. This feasibly 
explains the smaller size of the pregeniculate structures in subjects with glaucoma. 
However, in macular degeneration, the disease involves primarily the outer layer of 
the retina, where the choriocapillary tissue is damaged and the photoreceptors are 
disrupted. Direct involvement of the RGC in macular degeneration is currently 
unknown. Even so, the pregeniculate structures were markedly smaller than in the 
controls. Does this indicate RGC involvement in macular degeneration? I cannot say 
for certain from my studies, except that the pregeniculate structures are compromised 
in macular degeneration. 
! Second, involvement of the LGB, the geniculocalcarine radiation (GCR) and 
the primary visual cortex is apparent in both conditions, and most pronounced in 
glaucoma and JMD. These features were smaller, and the decline in size correlated 
with the severity of the visual field defect in glaucoma. The marked involvement of 
these structures in glaucoma and macular degeneration indicates that any 
degenerative changes occurring within the pathway is probably trans-synaptic in 
nature. If it is assumed that the pathology begins in the retina in both glaucoma and 
macular degeneration, even the previously discussed involvement of the pregeniculate 
structures indicates that whatever happened in the outer layer of the retina could 
influence the axons of the RGC. On the other hand, if the pathology begins in the 
primary visual cortex, it must have managed to find its way to adversely affect the 
LGB neurons and their axons (GCR), as well as the pregeniculate structures.  Even 
though my studies are incapable of determining  causality (because they had a cross-
sectional design), the findings led me to consider the probability of trans-synaptic 
degeneration, either anterogradely or retrogradely. 
! During  the studies, I also learned that the standard methods of image 
processing  have advantages as well as limitations. I was therefore compelled to 
develop improvements to the preprocessing  steps. The first development involved 
segmentation. Standard segmentation in SPM effectively separates the cortex from 
the rest of the brain. However, the  lateral geniculate bodies are still inseparable from 
the white matter. By modifying  tissue probability maps, or by applying  a six-class 
segmentation, I was able to automatically extract a previously less separable 
structures, the LGB in this case.
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The second development involved registration. The standard registration available in 
the softwares I used in my studies allows for adequate inter-brain registration. 
However, certain brain structures, in particular the pregeniculate structures and the 
geniculate bodies, were registered more effectively when the registration was applied 
locally, i.e. involving only the desired structure and not the whole brain. Since the 
validity of voxel-style statistics results is affected by the quality of registration, 
performing local registration to improve quality became a necessity, especially for the 
geniculate bodies and the pregeniculate structures. 
! Finally,  an investigator can never be 100% certain that what he or she has 
discovered is what really takes place in nature. To the best of my knowledge at the 
time this thesis was written, the image processing methodology and the statistical 
methods were reliable for inferring  the conclusions that were drawn.  Ideas on how to 
improve methodologies generally do not come in a batch, but one at a time, within a 
time period that may be short or long – depending  on one’s perspective. Because the 
confidence in one’s findings is based on the validity and reliability of the methods 
used, improving the methodology means improving the confidence in future findings. 
On the other hand, the improvements may cast doubt on previous findings. When this 
is the case, healthy scepticism and meticulous procedures are the main things I can 
rely on in my effort to understand what is really going on in the visual pathway.  
6.3. Future directions in research
The series of studies presented in this thesis suggest that retinal and optic nerve 
diseases should not be considered entirely ocular in nature. The apparent involvement 
of the retrobulbar pathway could perhaps encourage ophthalmologists to consider 
“treating the brain” and not just the eye. Clinically, collaboration between (neuro-)
ophthalmologists, glaucoma specialists, and neurologists should be encouraged to 
develop neuro-protective approaches to the diseases.  Meanwhile in the laboratory, 
collaboration between neuroscientists and pharmacologists will be essential to develop 
novel treatments that may protect the neurons from the effects of the disease. 
! The current development of neuro-imaging techniques, coupled with retinal 
imaging, can be expected to pave the way for more sensitive diagnostic imaging 
methods. Many advances have taken place in functional diagnostic techniques for 
vision examination, including  psychophysics, electroretinography and functional 
magnetic resonance imaging. Moreover, retinal and brain morphometry are not yet 
being  intensively used in vision impairment.  When combined, functional and 
structural analyses of the complete pathway from the eye to the visual cortex may 
ultimately provide us with much better comprehension of the dynamics of the visual 
pathway. This improved comprehension is expected to be important in the effective 










Vision is a crucial sensory function for humans.  People benefit from a visual field that 
is almost 180° wide from both top to bottom and from side to side, which allows them 
to be constantly aware of their surrounding. The most central part of this visual field 
is used for precision visual tasks, for example reading, observing the details of an 
object or recognising colours. We can refer to this part of the field as central vision. 
The peripheral field is useful when there is little light and it allows us to detect 
movement at the periphery of our vision. I will refer to this as peripheral vision. 
! Like any other bodily functions, the visual field can be affected by disease. 
Central vision may be lost in macular degeneration, where the light-receiving cells in 
the central part of the retina are disrupted (the retina is a layer at the back of the 
eyeball that receives and processes the light entering the eye). Peripheral vision may 
be lost due to glaucoma, where the retinal nerve cells distributed all over the retina 
begin to die.  Using MRI (magnetic resonance imaging), we studied the brain anatomy 
of subjects with these eye diseases. After several image processing steps, we compared 
the volume of parts of the brains of various patient and control groups. Specifically, 
we investigated the visual pathway, which is the part of the brain through which the 
visual information is transmitted from the eye to the part of the brain relevant to 
vision (the visual cortex). 
! Two general types of macular degeneration can be distinguished, based on the 
onset of the disease: the juvenile type (starts in childhood or teenage) and the age-
related type (starts in the fifth decade of life or later). We examined the brains of 
patients with macular degeneration and compared them to the brains of healthy 
individuals. We found that the visual pathway volume of patients with macular 
degeneration is lower than in healthy individuals (Chapters 2 and 3). This lower 
volume occurred along the entire pathway, from behind the eyeball to the brain, and 
this was most pronounced in the juvenile type of the disease. This might be caused by 
the fact that the disease starts early in life, and consequently the disease period is 
longer. 
! We also studied glaucoma, a disease that starts with loss of peripheral vision. 
Described in more detail in Chapters 2, 4,  and 5, we found that patients with 
glaucoma also have a lower visual pathway volume than healthy individuals. In 
addition, the volume and the integrity of the pathway is negatively correlated with the 
severity of the disease. The worse the visual field sensitivity, the smaller the volume of 
the visual pathway. 
! The results in this thesis indicate that glaucoma and macular degeneration are 
not strictly eye diseases,  but also involve the brain.  We argue that if the visual 
pathway and the brain have been adversely affected by an eye disease, vision 
restoration or rehabilitation effort may have less likelihood of success. We recommend 
to direct more attention towards the brain in the management of eye diseases such as 
macular degeneration and glaucoma. In our view, this should be done in the hope of 
preventing  widespread changes in the brain. Future studies should aim to find ways to 
protect the nerve cells in the brain from such change and damage. 
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Samenvatting
Het gezichtsvermogen is een cruciale sensorische functie voor de mens. Mensen 
hebben een gezichtsveld dat van boven naar beneden en van links naar rechts bijna 
een gebied van 180 graden omvat. Hierdoor zijn zij  zich constant bewust van hun 
omgeving. Het centrale deel van het gezichtsveld, de fovea of macula, wordt gebruikt 
voor nauwkeurige visuele taken zoals lezen, het waarnemen van details van een object 
of het herkennen van kleuren. De rest van het gezichtsveld, ook wel het perifere 
gezichtsveld genoemd, geeft ons overzicht en stelt ons in staat om beweging waar te 
nemen. Het stelt ons ook in staat om nog wat zien wanneer er weinig licht is.
! Het netvlies is een laag  met zenuwcellen aan de achterkant van het oog. Het 
netvlies vangt het licht op dat binnenvalt in het oog en zet dit om in een neuraal 
signaal. Net als andere lichaamsfuncties kan het netvlies, en daarmee het gezichtsveld, 
worden aangetast door ziektes.  Het centrale gezichtsveld kan aangetast worden door 
maculadegeneratie, waarbij  de zenuwcellen in het centrale deel van het netvlies 
beschadigd worden. Bij de oogziekte glaucoom wordt vooral het perifere deel van het 
netvlies aangetast. Met behulp van MRI (magnetic resonance imaging) hebben we 
beelden gemaakt van de hersenen van patiënten met deze oogziekten. Na een 
uitgebreide bewerking van deze beelden konden we de inhoud van delen van de 
hersenen van verschillende patiënten- en controlegroepen vergelijken. Hierbij hebben 
we specifiek gekeken naar de visuele banen.  Dat is het deel van de hersenen waar de 
visuele informatie van het oog  wordt doorgegeven naar het deel van de hersenen dat 
betrokken is bij het zien (de visuele cortex). 
! De oogziekte maculadegeneratie kan worden onderverdeeld in twee types, 
gebaseerd op het moment van aanvang van de ziekte. Het juveniele type begint in de 
kinder- of tienerjaren. Het leeftijdgebonden type begint meestal na het vijftigste 
levensjaar. We onderzochten de hersenen van patiënten met maculadegeneratie en 
vergeleken ze met de hersenen van gezonde personen. We vonden dat de visuele 
banen van patiënten met maculadegeneratie een minder grote inhoud hadden dan die 
van gezonde personen (hoofdstuk 2 en 3). Deze kleinere inhoud vonden we langs de 
hele lijn van visuele banen; van achter het oog  tot aan de hersenen. De kleinere 
inhoud was het meest uitgesproken bij de juveniele vorm van maculadegeneratie.  Dit 
kan het gevolg zijn van het feit dat deze ziekte al eerder tijdens het leven begint, 
waardoor de ziekte bij de proefpersonen al verder gevorderd was.
! Ook bij de patiënten met glaucoom vonden we een verminderde inhoud van de 
visuele banen ten opzichte van gezonde individuen. Daarnaast vonden we dat bij deze 
patiënten de inhoud van de visuele banen samenhing  met de gevoeligheid van het 
gezichtsveld, hetgeen een maat is voor de ernst van de ziekte. Hoe lager de 
gevoeligheid van het gezichtsveld, des te kleiner bleek het volume van de visuele 
banen. Dit is meer in detail beschreven in de hoofdstukken 2, 4, en 5.
! De resultaten in dit proefschrift geven aan dat glaucoom en maculadegeneratie 
niet alleen oogziekten zijn, maar ook invloed kunnen hebben op de hersenen. 
Mogelijk is het dus zo dat als de visuele banen in de hersenen zijn aangetast door een 
oogziekte, eventueel herstel van het gezichtsvermogen of revalidatie minder kans op 
succes hebben. Wij adviseren daarom om bij de behandeling van oogziekten, zoals 
maculadegeneratie en glaucoom, ook aandacht te besteden aan de hersenen. Daarmee 
kunnen grootschalige veranderingen in de hersenen worden voorkomen. Toekomstige 
studies zullen manieren moeten gaan vinden om de zenuwcellen in de hersenen te 
beschermen tegen veranderingen  en beschadigingen.
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Ringkasan
Penglihatan adalah fungsi inderawi yang penting bagi manusia. Manusia 
mendapatkan manfaat dari luasnya lapangan pandang  yang hampir 180° dari atas ke 
bawah dan dari sisi ke sisi, yang memungkinkan manusia menyadari lingkungan 
sekitarnya secara berkesinambungan. Bagian yang  paling tengah dari lapangan 
pandang  dipakai untuk tugas-tugas penglihatan yang  membutuhkan ketepatan, 
misalnya untuk membaca, mengamati rincian benda atau mengenali warna. Lapangan 
pandang  tersebut kita sebut juga lapangan pandang  tengah. Lapangan pandang tepi 
sangat berguna ketika hanya ada sedikit cahaya dan memungkinkan manusia 
mendeteksi gerakan di pinggiran lapangan pandang. Lapangan pandang ini kita sebut 
juga lapangan pandang tepi. 
! Seperti fungsi tubuh lainnya, lapangan pandang  bisa dipengaruhi oleh 
penyakit. Lapangan pandang tengah bisa rusak akibat degenerasi makula, dimana sel-
sel peka cahaya di bagian tengah selaput jala terganggu (selaput jala adalah lapisan 
pada bagian belakang dalam bola mata yang  menerima dan memproses cahaya yang 
memasuki mata). Lapangan pandang tepi bisa rusak akibat glaukoma, dimana sel-sel 
saraf yang  tersebar luas di selaput jala mati satu per satu. Menggunakan pencitraan 
resonansi magnetik (MRI - magnetic resonance imaging), kami mempelajari anatomi otak 
para pasien dengan penyakit mata. Setelah melalui beberapa langkah pengolahan 
citra, kami bandingkan citra otak kelompok pasien dengan kelompok kontrol (orang 
sehat). Dengan memakai teknik pengolahan citra kami menyelidiki ukuran bagian-
bagian otak yang melayani fungsi penglihatan (kortels visual).
! Secara umum, dapat dibedakan dua jenis degenerasi makula berdasarkan 
waktu timbulnya penyakit: jenis remaja (mulai anak-anak atau remaja) dan jenis yang 
terkait penuaan (dimulai pada dekade kelima dari kehidupan atau lambat).  Kami 
memeriksa otak pasien dengan degenerasi makula dan membandingkannya dengan 
otak orang sehat. Secara lebih spesifik, kami meneliti jaras penglihatan, yaitu bagian 
yang menjembatani lalu lintas informasi penglihatan dari mata ke otak. Kami 
menemukan bahwa ukuran jaras penglihatan pasien dengan degenerasi makula lebih 
kecil dibandingkan ukuran jaras penglihatan orang sehat (Bab 2 dan 3). Kecilnya 
ukuran jaras ini terdeteksi di sepanjang  jaras, mulai dari belakang  bola mata hingga ke 
otak. Temuan ini lebih menonjol  pada degenerasi makula jenis remaja. Hal ini bisa jadi 
karena degenerasi makula jenis remaja muncul lebih awal (usia muda) sehingga masa 
sakitnya labih panjang.
! Kami juga meneliti glaukoma, suatu penyakit yang dimulai dengan hilangnya 
penglihatan tepi.  Dijelaskan secara lebih rinci dalam Bab 2, 4 dan 5, kami menemukan 
bahwa pasien dengan glaukoma juga memiliki ukuran jaras penglihatan yang  lebih 
kecil daripada orang sehat. Selain itu, jaras dan keutuhan jaras berhubungan dengan 
keparahan penyakit. Semakin buruk kepekaan lapangan pandang, semakin kecil 
ukuran jaras penglihatan.
! Hasil studi dalam disertasi ini menunjukkan bahwa glaukoma dan degenerasi 
makula bukan sekedar penyakit mata,  namun juga melibatkan otak. Kami 
berpendapat bahwa jika jaras penglihatan dan otak telah terpengaruh oleh penyakit 
mata, upaya pemulihan atau rehabilitasi penglihatan akan lebih sulit berhasil.  Kami 
menyarankan untuk menambah perhatian kepada otak dalam pengelolaan penyakit 
mata, terutama degenerasi makula dan glaukoma. Dengan demikian, kami berharap 
keterlibatan yang lebih luas di otak bisa diantisipasi. Penelitian di masa depan 





3D! three dimensional 
AMD!! age-related macular degeneration
ANCOVA! analysis of covariance
AP ! ! antero-posterior, directional parameter in diffusion-weighted acquisition
BCN! The Research School of Behavioural and Cognitive Neurosciences, 
University of Groningen
BET! Brain Extraction Tool, a part of FSL
CSF/csf! cerebrospinal fluid
DARTEL ! Diffeomorphic Anatomical Registration through Exponentiated Lie 
Algebra 
dB! ! decibel





JMD!! juvenile-type macular degeneration
MD ! mean deviation (of the sensitivity of the visual field)
MDEFT! modified driven equilibrium Fourier transform 
NIFTI! Neuroimaging Informatics Technology Initiative 
FA! fractional anisotropy
FAST! FMRIB’s Automated Segmentation Tool
FMRIB! Functional Magnetic Resonance Imaging of the Brain
FOV! field of view
FSL! FMRIB Software Library, developed by FMRIB Analysis Group, 
Oxford, United Kingdom
FSPGR! fast-spoiled gradient recalled (echo pulse sequence) 
FWE! family-wise error
fwhm! full-width half-maximum
LGB/lgb! lateral geniculate body, synonymous to lateral geniculate nucleus
LGN/lgn! lateral geniculate nucleus, synonymous to lateral geniculate body
LLGN! left lateral geniculate nucleus 
logMAR! the logarithm of the minimum angle of resolution
LON ! left optic nerve !
LOR! left optic radiation
LOT! left optic tract 
MRI! ! magnetic resonance imaging
OC! optic chiasm 
ocp! occipital pole
PA! ! postero-anterior, directional parameter in diffusion-weighted acquisition
pgcl! pre-geniculate
POAG! primary open-angle glaucoma
RPE !! retinal pigment epithelium
RNFL! retinal nerve fiber layer
RGC!! retinal ganglion cell
RLGN! right lateral geniculate nucleus 
ROI! region-of-interest
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RON! right optic nerve
ROR! right optic radiation 
ROT! right optic tract 
scc! supracalcarine cortex
SITA! Swedish Interactive Threshold Algorithm
SPM5! Statistical Parametric Mapping version 2005
SPM8! Statistical Parametric Mapping version 2008
SPM99! Statistical Parametric Mapping version 1999
SUSAN! Smallest Univalue Segment Assimilating Nucleus
T1/T1! Also known as spin lattice time or relaxation time, a time taken by 
protons to realign themselves to the external magnetic field
T1W/T1W! T1-weighted acquisition with most contrasts due to T1 value
TBSS! tract-based spatial statistics 
TFCE! threshold-free cluster enhancement
TFE! turbo field echo
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